To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi
Title and authors | Publication | Year |
---|---|---|
Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas.
Agathangelidis A, Roussos A, Kardamiliotis K, Psomopoulos F, Stamatopoulos K |
Methods in molecular biology (Clifton, N.J.) | 2025 |
Expression Cloning of Antibodies from Single Human B Cells.
Rollenske T, Murugan R, Wardemann H, Busse CE |
Methods in molecular biology (Clifton, N.J.) | 2025 |
Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine?
Tsagiopoulou M, Gut IG |
Frontiers in Genetics | 2024 |
B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia
Schmid VK, Hobeika E |
Frontiers in Oncology | 2024 |
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Angotzi F, Cellini A, Ruocco V, Cavarretta CA, Zatta I, Serafin A, Pravato S, Pagnin E, Bonaldi L, Frezzato F, Facco M, Piazza F, Trentin L, Visentin A |
Cancers | 2024 |
B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice
Hayakawa K, Zhou Y, Shinton SA |
Immunity & ageing : I & A | 2024 |
An overview of prognostic markers in patients with CLL
Braish J, Cerchione C, Ferrajoli A |
Frontiers in Oncology | 2024 |
Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.
Shao Q, Wykretowicz J, Hu N, Bedi K, Rizk M, Malek IA, Kumar S, Lombard DB, Shedden K, Scott D, Malek SN |
Leukemia | 2024 |
慢性淋巴细胞白血病中B细胞受体同型模式的生物学特征和临床意义
|
Chinese Journal of Hematology | 2024 |
Genetic Lesions in Russian CLL Patients with the Most Common Stereotyped Antigen Receptors.
Biderman BV, Likold EB, Severina NA, Obukhova TN, Sudarikov AB |
Genes & development | 2023 |
Circular RNA Expression Signatures Provide Promising Diagnostic and Therapeutic Biomarkers for Chronic Lymphocytic Leukemia.
Gharib E, Nasrabadi PN, Robichaud GA |
Cancers | 2023 |
CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring
Vergani S, Bagnara D, Agathangelidis A, Ng AK, Ferrer G, Mazzarello AN, Palacios F, Yancopoulos S, Yan XJ, Barrientos JC, Rai KR, Stamatopoulos K, Chiorazzi N |
Frontiers in Oncology | 2023 |
The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives.
Eyre TA, Riches JC |
Cancers | 2023 |
The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia.
Chatzidavid S, Kontandreopoulou CN, Diamantopoulos PT, Giannakopoulou N, Katsiampoura P, Stafylidis C, Dryllis G, Kyrtsonis MC, Dimou M, Panayiotidis P, Viniou NA |
2023 | |
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform Comparison.
Petrova-Drus K, Syed M, Yu W, Hutt K, Zlotnicki AM, Huang Y, Kamalska-Cyganik M, Maciag L, Wang M, Ma YG, Ho C, Moung C, Yao J, Nafa K, Baik J, Vanderbilt CM, Benhamida JK, Liu Y, Zhu M, Durham B, Ewalt MD, Salazar P, Rijo I, Baldi T, Mato A, Roeker LE, Roshal M, Dogan A, Arcila ME |
The Journal of molecular diagnostics : JMD | 2023 |
The inhibitory receptor Siglec‐G controls the severity of chronic lymphocytic leukemia
Röder B, Fahnenstiel H, Schäfer S, Budeus B, Dampmann M, Eichhorn M, Angermüller S, Brost C, Winkler TH, Seifert M, Nitschke L |
EMBO reports | 2023 |
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy.
Morabito F, Adornetto C, Monti P, Amaro A, Reggiani F, Colombo M, Rodriguez-Aldana Y, Tripepi G, D'Arrigo G, Vener C, Torricelli F, Rossi T, Neri A, Ferrarini M, Cutrona G, Gentile M, Greco G |
Frontiers in Oncology | 2023 |
Chronic Lymphocytic Leukemia: Disease Biology
Koehrer S, Burger JA |
Acta haematologica | 2023 |
B-cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia
Andrea N. Mazzarello, Eva Gentner-Göbel, Marcus Dühren-von Minden, Tatyana Tarasenko, Antonella Nicolò, Gerardo Ferrer, Stefano Vergani, Yun Liu, Davide Bagnara, Kanti Rai, Jan A. Burger, Peter J. McGuire, Palash C. Maity, Hassan Jumaa, Nicholas Chiorazzi |
Journal of Clinical Investigation | 2022 |
Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements.
Bagnara D, Colombo M, Reverberi D, Matis S, Massara R, Cardente N, Ubezio G, Agostini V, Agnelli L, Neri A, Cardillo M, Vergani S, Ghiotto F, Mazzarello AN, Morabito F, Cutrona G, Ferrarini M, Fais F |
Frontiers in Oncology | 2022 |
InterTADs: integration of multi-omics data on topologically associated domains, application to chronic lymphocytic leukemia.
Tsagiopoulou M, Pechlivanis N, Maniou MC, Psomopoulos F |
NAR genomics and bioinformatics | 2022 |
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
Olbertova H, Plevova K, Pavlova S, Malcikova J, Kotaskova J, Stranska K, Spunarova M, Trbusek M, Navrkalova V, Dvorackova B, Tom N, Pal K, Jarosova M, Brychtova Y, Panovska A, Doubek M, Pospisilova S |
BMC Cancer | 2022 |
Next-Generation Sequencing Revealed a Distinct Immunoglobulin Repertoire with Specific Mutation Hotspots in Acute Myeloid Leukemia.
Xia M, Wu L, Sun X, Han X, Yan H, Huang J, Zhang Y, Hu Z, Zu Y, Yin CC, Qiu X |
Biology | 2022 |
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay.
Mimmi S, Maisano D, Dattilo V, Gentile M, Chiurazzi F, D'Ambrosio A, Zimbo A, Nisticò N, Aloisio A, Vecchio E, Fiume G, Iaccino E, Quinto I |
Biomedicines | 2022 |
Immunoglobulin Gene Sequence as an Inherited and Acquired Risk Factor for Chronic Lymphocytic Leukemia.
Datta M, Jumaa H |
Cancers | 2022 |
Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia
Bagnara D, Mazzarello AN, Ghiotto F, Colombo M, Cutrona G, Fais F, Ferrarini M |
International journal of molecular sciences | 2022 |
Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study.
Yao CY, Agathangelidis A, Chuang SS, Tsou HH, Feng WL, Liu TC, Chen TY, Yu YB, Yeh SP, Yao M, Wang CC, Lin J, Hwang WL, Gau JP, Chou WC, Chao TY, Lin LI, Tien HF, Ghia P, Wu SJ |
HemaSphere | 2022 |
Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity.
Sofou E, Zaragoza-Infante L, Pechlivanis N, Karakatsoulis G, Notopoulou S, Stavroyianni N, Psomopoulos F, Georgiou E, de Septenville AL, Davi F, Agathangelidis A, Chatzidimitriou A, Stamatopoulos K |
Frontiers in Oncology | 2022 |
Exploring the pathways to chronic lymphocytic leukemia
FK Stevenson, F Forconi, TJ Kipps |
Blood | 2021 |
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia
A Ng, N Chiorazzi |
Hematology/Oncology Clinics of North America | 2021 |
The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia
E Vlachonikola, E Sofou, A Chatzidimitriou, K Stamatopoulos, A Agathangelidis |
Hematology/Oncology Clinics of North America | 2021 |
Reading the B-cell receptor immunome in chronic lymphocytic leukemia: revelations and applications
PJ Hengeveld, MD Levin, PM Kolijn, AW Langerak |
Experimental Hematology | 2021 |
Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin
M Gerousi, S Laidou, K Gemenetzi, K Stamatopoulos, A Chatzidimitriou |
Frontiers in Oncology | 2021 |
AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression
P Oppezzo, M Navarrete, N Chiorazzi |
Frontiers in Oncology | 2021 |
A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice
PE Patten, G Ferrer, SS Chen, JE Kolitz, KR Rai, SL Allen, JC Barrientos, N Ioannou, AG Ramsay, N Chiorazzi |
Frontiers in immunology | 2021 |
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
F Morabito, G Tripepi, R Moia, AG Recchia, P Boggione, FR Mauro, S Bossio, G DArrigo, EA Martino, E Vigna, F Storino, G Fronza, FD Raimondo, D Rossi, A Condoluci, M Colombo, F Fais, S Fabris, R Foa, G Cutrona, M Gentile, E Montserrat, G Gaidano, M Ferrarini, A Neri |
Frontiers in Oncology | 2021 |
Chronic lymphocytic leukemia–like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia
G Blanco, A Puiggros, B Sherry, L Nonell, X Calvo, E Puigdecanet, PY Chiu, Y Kieso, G Ferrer, F Palacios, M Arnal, M Rodríguez-Rivera, E Gimeno, E Abella, KR Rai, P Abrisqueta, F Bosch, A Calon, A Ferrer, N Chiorazzi, B Espinet |
Experimental Hematology | 2021 |
The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome
A Rodríguez-Caballero, BF Herrero, GO Ariza, I Criado, M Alcoceba, C Prieto, MP Caro, AC García-Montero, MG Díaz, F Forconi, AB Sarmento-Ribeiro, J Almeida, A Orfao |
Frontiers in Oncology | 2021 |
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course
D Bagnara, C Tang, JR Brown, S Kasar, S Fernandes, M Colombo, S Vergani, AN Mazzarello, F Ghiotto, S Bruno, F Morabito, KR Rai, JE Kolitz, JC Barrientos, SL Allen, F Fais, MD Scharff, T MacCarthy, N Chiorazzi |
Frontiers in Oncology | 2021 |
T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
E Vlachonikola, K Stamatopoulos, A Chatzidimitriou |
Frontiers in immunology | 2021 |
MARCKS affects cell motility and response to BTK inhibitors in CLL
L Beckmann, V Berg, C Dickhut, C Sun, O Merkel, J Bloehdorn, S Robrecht, M Seifert, A da Palma Guerreiro, J Claasen, S Loroch, M Oliverio, C Underbayev, L Vaughn, D Thomalla, MF Hülsemann, E Tausch, K Fischer, AM Fink, B Eichhorst, A Sickmann, CM Wendtner, S Stilgenbauer, M Hallek, A Wiestner, RP Zahedi, LP Frenzel |
Blood | 2021 |
Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer
T Sadras, M Martin, K Kume, ME Robinson, S Saravanakumar, G Lenz, Z Chen, JY Song, T Siddiqi, L Oksa, AM Knapp, J Cutler, KN Cosgun, L Klemm, V Ecker, J Winchester, D Ghergus, P Soulas-Sprauel, F Kiefer, N Heisterkamp, A Pandey, V Ngo, L Wang, H Jumaa, M Buchner, J Ruland, WC Chan, E Meffre, T Martin, M Müschen |
Molecular Cell | 2021 |
Developmental changes in the rules for B cell selection
S Vergani, J Yuan |
Immunological Reviews | 2021 |
The Traf2DNxBCL2-tg Mouse Model of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recapitulates the Biased IGHV Gene Usage, Stereotypy, and Antigen-Specific HCDR3 Selection of Its Human Counterpart
G Perez-Chacon, JM Zapata |
Frontiers in immunology | 2021 |
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
A Agathangelidis, A Chatzidimitriou, K Gemenetzi, V Giudicelli, M Karypidou, K Plevova, Z Davis, XJ Yan, S Jeromin, C Schneider, LB Pedersen, RC Tschumper, LA Sutton, P Baliakas, L Scarfò, EJ van Gastel, M Armand, E Tausch, B Biderman, C Baer, D Bagnara, A Navarro, AL de Septenville, V Guido, G Mitterbauer-Hohendanner, A Dimovski, C Brieghel, S Lawless, M Meggendorfer, K Brazdilova, M Ritgen, M Facco, C Tresoldi, A Visentin, A Patriarca, M Catherwood, L Bonello, A Sudarikov, K Vanura, M Roumelioti, HS Francova, T Moysiadis, S Veronese, K Giannopoulos, L Mansouri, T Karan-Djurasevic, R Sandaltzopoulos, C Bödör, F Fais, A Kater, I Panovska, D Rossi, S Alshemmari, P Panagiotidis, P Costeas, B Espinet, D Antic, L Foroni, M Montillo, L Trentin, N Stavroyianni, G Gaidano, PF di Celle, C Niemann, E Campo, A Anagnostopoulos, C Pott, K Fischer, M Hallek, D Oscier, S Stilgenbauer, C Haferlach, D Jelinek, N Chiorazzi, S Pospisilova, MP Lefranc, S Kossida, AW Langerak, C Belessi, F Davi, R Rosenquist, P Ghia, K Stamatopoulos |
Blood | 2021 |
[Distinguish immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Chinese patients with chronic lymphocytic leukemia].
Li H, Wang TY, Yin Y, Wang PL, Cheng Z, Li JP, Li W, Zhu FY, Wu CC, Luo ZM, Chen YH, Xiao H, Deng SB, Cao YQ, Zhang GS, Qiu LG, Peng HL |
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2021 |
Overcoming resistance to targeted therapies in chronic lymphocytic leukemia
SS Skånland, AR Mato |
Blood Advances | 2021 |
Flow Cytometry of Hematological Malignancies
C Ortolani |
Flow Cytometry of Hematological Malignancies | 2021 |
Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic Cells
M Kotrova, N Darzentas, C Pott, CD Baldus, M Brüggemann |
Genes & development | 2021 |
Chronic lymphocytic leukemia in a young population
SH Alshemmari, A Hamdah, R Pandita, A Kunhikrishnan |
Leukemia Research | 2021 |
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway
CI Smith, JA Burger |
Frontiers in immunology | 2021 |
Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia
ML Boulland, S Vic, F Thonier, M Ganard, T Lamy, T Fest, S de Guibert, C Pastoret |
Leukemia & Lymphoma | 2021 |
Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases
BV Biderman, EB Likold, SY Smirnova, EA Nikitin, DA Koroleva, EE Zvonkov, LS Al-Radi, HL Julhakyan, AB Sudarikov |
Clinical Lymphoma, Myeloma & Leukemia | 2021 |
Characterizing the BCR repertoire during lymphocyte reduction and recovery mediated by cyclophosphamide and granulocyte-macrophage colony-stimulating factor
J Li, Y Li, S Sun, L Yang, L Ma, B Shi, R Ma, X Yao |
International Immunopharmacology | 2021 |
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
C Galigalidou, L Zaragoza-Infante, A Iatrou, A Chatzidimitriou, K Stamatopoulos, A Agathangelidis |
Frontiers in Oncology | 2021 |
Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia.
Ciardullo C, Szoltysek K, Zhou P, Pietrowska M, Marczak L, Willmore E, Enshaei A, Walaszczyk A, Ho JY, Rand V, Marshall S, Hall AG, Harrison CJ, Soundararajan M, Eswaran J |
Cancers | 2021 |
Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies
DG Efremov, S Turkalj, L Laurenti |
Cancers | 2020 |
B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemia
SS Skånland, L Karlsen, K Taskén |
Scandinavian Journal of Immunology | 2020 |
Celebrating 20 Years of IGHV Mutation Analysis in CLL:
N Chiorazzi, FK Stevenson |
2020 | |
CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation
BA Bartholdy, X Wang, XJ Yan, M Pascual, M Fan, J Barrientos, SL Allen, JA Martinez-Climent, KR Rai, N Chiorazzi, MD Scharff, S Roa |
Blood Advances | 2020 |
B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making
K Gemenetzi, A Agathangelidis, L Zaragoza-Infante, E Sofou, M Papaioannou, A Chatzidimitriou, K Stamatopoulos |
Frontiers in Oncology | 2020 |
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia
A Lupia, S Mimmi, E Iaccino, D Maisano, F Moraca, C Talarico, E Vecchio, G Fiume, F Ortuso, G Scala, I Quinto, S Alcaro |
European Journal of Medicinal Chemistry | 2020 |
Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients
A Bosseboeuf, C Seillier, N Mennesson, S Allain-Maillet, M Fourny, A Tallet, E Piver, P Lehours, F Mégraud, L Berthelot, J Harb, E Bigot-Corbel, S Hermouet |
Frontiers in immunology | 2020 |
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
P Monti, M Lionetti, GD Luca, P Menichini, AG Recchia, S Matis, M Colombo, S Fabris, A Speciale, M Barbieri, M Gentile, S Zupo, M Dono, A Ibatici, A Neri, M Ferrarini, F Fais, G Fronza, G Cutrona, F Morabito |
Scientific Reports | 2020 |
Non-Hodgkin Lymphomas: Malignancies Arising from Mature B Cells
J Shingleton, J Wang, C Baloh, T Dave, N Davis, L Happ, O Jadi, R Kositsky, X Li, C Love, R Panea, Q Qin, A Reddy, N Singhi, E Smith, D Thakkar, SS Dave |
Cold Spring Harbor Perspectives in Medicine | 2020 |
Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing
SK Gupta, DS Viswanatha, KP Patel |
Frontiers in Cell and Developmental Biology | 2020 |
Precision Medicine Management of Chronic Lymphocytic Leukemia
R Moia, A Patriarca, M Schipani, V Ferri, C Favini, S Sagiraju, WA Essa, G Gaidano |
Cancers | 2020 |
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study
AC Leeksma, P Baliakas, T Moysiadis, A Puiggros, K Plevova, AM der Kevie-Kersemaekers, H Posthuma, AE Rodriguez-Vicente, AN Tran, G Barbany, L Mansouri, R Gunnarsson, H Parker, EV den Berg, M Bellido, Z Davis, M Wall, I Scarpelli, A Österborg, L Hansson, M Jarosova, P Ghia, P Poddighe, B Espinet, S Pospisilova, C Tam, L Ysebaert, F Nguyen-Khac, D Oscier, C Haferlach, J Schoumans, M Stevens-Kroef, E Eldering, K Stamatopoulos, R Rosenquist, JC Strefford, C Mellink, AP Kater |
Haematologica | 2020 |
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach
M Colombo, D Bagnara, D Reverberi, S Matis, M Cardillo, R Massara, L Mastracci, JL Ravetti, L Agnelli, A Neri, M Mazzocco, M Squillario, AN Mazzarello, G Cutrona, A Agathangelidis, K Stamatopoulos, M Ferrarini, F Fais |
Molecular Medicine | 2020 |
Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review
E Grywalska, M Zaborek, J Łyczba, R Hrynkiewicz, D Bębnowska, R Becht, B Sosnowska-Pasiarska, J Smok-Kalwat, M Pasiarski, S Góźdź, J Roliński, P Niedźwiedzka-Rystwej |
Cells | 2020 |
HLA allele repertoire in Russian chronic lymphocytic leukemia patients with an unfavorable prognosis
BV Biderman, EB Likold, AR Abdrakhimova, EA Leonov, EG Khamaganova, AB Sudarikov |
2020 | |
Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics
R Moia, A Patriarca, AM Mahmoud, V Ferri, C Favini, S Rasi, C Deambrogi, G Gaidano |
Expert Opinion on Orphan Drugs | 2020 |
Lymphoma: Methods and Protocols
R Küppers |
2019 | |
Lymphoma: Methods and Protocols
R Küppers |
2019 | |
BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo
C Schleiss, W Ilias, O Tahar, Y Güler, L Miguet, C Mayeur-Rousse, L Mauvieux, LM Fornecker, E Toussaint, R Herbrecht, F Bertrand, M Maumy-Bertrand, T Martin, S Fournel, P Georgel, S Bahram, L Vallat |
Scientific Reports | 2019 |
Another step forward in the 20-year history of IGHV mutations in chronic lymphocytic leukemia
ID Giudice, R Foà |
Haematologica | 2019 |
A practical guide for mutational signature analysis in hematological malignancies
F Maura, A Degasperi, F Nadeu, D Leongamornlert, H Davies, L Moore, R Royo, B Ziccheddu, XS Puente, H Avet-Loiseau, PJ Campbell, S Nik-Zainal, E Campo, N Munshi, N Bolli |
Nature Communications | 2019 |
Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia
YJ Huang, MC Kuo, H Chang, PN Wang, JH Wu, YM Huang, MC Ma, TC Tang, CY Kuo, LY Shih |
British Journal of Haematology | 2019 |
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia: TP63 in CLL
N Papakonstantinou, S Ntoufa, M Tsagiopoulou, T Moysiadis, S Bhoi, A Malousi, F Psomopoulos, L Mansouri, S Laidou, D Papazoglou, M Gounari, K Pasentsis, K Plevova, V Kuci-Emruli, M Duran-Ferrer, Z Davis, S Ek, D Rossi, G Gaidano, M Ritgen, D Oscier, N Stavroyianni, S Pospisilova, F Davi, P Ghia, A Hadzidimitriou, C Belessi, JI Martin-Subero, C Pott, R Rosenquist, K Stamatopoulos |
International Journal of Cancer | 2019 |
Updates in the management of chronic lymphocytic leukemia/small lymphocytic leukemia
KS Hanna |
Journal of Oncology Pharmacy Practice | 2019 |
The B‐cell receptor in control of tumor B‐cell fitness: Biology and clinical relevance
S Casola, L Perucho, C Tripodo, P Sindaco, M Ponzoni, F Facchetti |
Immunological Reviews | 2019 |
98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia
K Shi, Q Sun, C Qiao, H Zhu, L Wang, J Wu, L Wang, J Fu, KH Young, L Fan, Y Xia, W Xu, J Li |
Cancer Medicine | 2019 |
The Impact and Prognostic Significance of Chronic Lymphocytic Leukemia Upregulated 1 (CLLU1) Gene Expression in Patients with Chronic Lymphocytic Leukemia: A Single Center Experience
M Sevinc, A Karabulut, AE Eskazan, SC Tatonyan, U Ozbek, T Soysal |
Laboratory Medicine | 2019 |
Combined Influence of B-Cell Receptor Rearrangement and Somatic Hypermutation on B-Cell Class-Switch Fate in Health and in Chronic Lymphocytic Leukemia
VN Petrova, L Muir, PF McKay, GS Vassiliou, KG Smith, PA Lyons, CA Russell, CA Anderson, P Kellam, RJ Bashford-Rogers |
Frontiers in immunology | 2018 |
Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy
JA Burger, S OBrien |
Nature Reviews Clinical Oncology | 2018 |
Chronic Lymphocytic Leukemia–Derived IL-10 Suppresses Antitumor Immunity
SS Alhakeem, MK McKenna, KZ Oben, SK Noothi, JR Rivas, GC Hildebrandt, RA Fleischman, VM Rangnekar, N Muthusamy, S Bondada |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
G Blanco, A Vardi, A Puiggros, A Gómez-Llonín, M Muro, M Rodríguez-Rivera, E Stalika, E Abella, E Gimeno, M López-Sánchez, A Senín, X Calvo, P Abrisqueta, F Bosch, A Ferrer, K Stamatopoulos, B Espinet |
OncoImmunology | 2018 |
Assessing human B cell repertoire diversity and convergence
K Imkeller, H Wardemann |
Immunological Reviews | 2018 |
The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia
E ten Hacken, M Gounari, P Ghia, JA Burger |
Leukemia | 2018 |
Double sword role of EZH2 in leukemia
S Safaei, B Baradaran, MF Hagh, MR Alivand, M Talebi, T Gharibi, S Solali |
Biomedicine & Pharmacotherapy | 2018 |
Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia
ED Rout, RC Burnett, JD Labadie, JA Yoshimoto, AC Avery, S Bondada |
PloS one | 2018 |
Strategies to overcome resistance mutations of Bruton's tyrosine kinase inhibitor ibrutinib
L Liu, B Shi, X Wang, H Xiang |
Future Medicinal Chemistry | 2018 |
Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones
SV Meeren, B Heyrman, W Renmans, M Bakkus, B Maes, HD Raeve, R Schots, K Jochmans |
Annals of Hematology | 2018 |
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, H Döhner, P Hillmen, M Keating, E Montserrat, N Chiorazzi, S Stilgenbauer, KR Rai, JC Byrd, B Eichhorst, S OBrien, T Robak, JF Seymour, TJ Kipps |
Blood | 2018 |
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent
A Rigo, I Ferrarini, A Bonalumi, C Tecchio, A Montresor, C Laudanna, F Vinante |
Oncotarget | 2018 |
A phase 2 study of ofatumumab (Arzerra ® ) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)*
CI Chen, H Paul, LW Le, EN Wei, S Snitzler, T Wang, O Levina, S Kakar, A Lau, M Queau, JB Johnston, DA Smith, S Trudel |
Leukemia & Lymphoma | 2018 |
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases
F Morabito, TD Shanafelt, M Gentile, G Reda, FR Mauro, D Rossi, ND Renzo, S Molica, F Angrilli, A Chiarenza, G Cutrona, KG Chaffee, SA Parikh, G Tripepi, G D'Arrigo, E Vigna, AG Recchia, A Cortelezzi, G Gaidano, FD Raimondo, F Fais, R Foà, A Neri, M Ferrarini |
American Journal of Hematology | 2018 |
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
LV Abruzzo, CD Herling, GA Calin, C Oakes, LL Barron, HE Banks, V Katju, MJ Keating, KR Coombes |
Haematologica | 2018 |
A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)
CI Chen, H Paul, S Snitzler, S Kakar, LW Le, EN Wei, A Lau, JB Johnston, SB Gibson, M Queau, D Spaner, D Croucher, B Sherry, S Trudel |
Leukemia & Lymphoma | 2018 |
Pathologie: Knochenmark, Lymphatisches System, Milz, Thymus
HK Müller-Hermelink, HH Kreipe |
2018 | |
Chronic lymphocytic leukaemia
TJ Kipps, FK Stevenson, CJ Wu, CM Croce, G Packham, WG Wierda, S O'Brien, J Gribben, K Rai |
Nature Reviews Disease Primers | 2017 |
Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation
R Catera, Y Liu |
Molecular Medicine | 2017 |
The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia
C Yuan, CC Chu, XJ Yan, D Bagnara, N Chiorazzi, T MacCarthy, JM di Noia |
PloS one | 2017 |
Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70
AA Gladkikh, DM Potashnikova, V Tatarskiy, M Yastrebova, A Khamidullina, N Barteneva, I Vorobjev |
Cancer Medicine | 2017 |
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia
EJ Murphy, DS Neuberg, LZ Rassenti, G Hayes, R Redd, C Emson, K Li, JR Brown, WG Wierda, S Turner, AW Greaves, CS Zent, JC Byrd, C McConnel, J Barrientos, N Kay, MK Hellerstein, N Chiorazzi, TJ Kipps, KR Rai |
Leukemia | 2017 |
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL Pathway
C Marini, S Bruno, F Fiz, C Campi, R Piva, G Cutrona, S Matis, A Nieri, M Miglino, A Ibatici, AM Orengo, AM Massone, CE Neumaier, D Totero, P Giannoni, M Bauckneht, M Pennone, C Tenca, E Gugiatti, A Bellini, A Borra, E Tedone, H Efetürk, F Rosa, L Emionite, M Cilli, D Bagnara, V Brucato, P Bruzzi, M Piana, F Fais, G Sambuceti |
Scientific Reports | 2017 |
Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia
N Purroy, CJ Wu |
Cold Spring Harbor Perspectives in Medicine | 2017 |
Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope.
Avnir Y, Prachanronarong KL, Zhang Z, Hou S, Peterson EC, Sui J, Zayed H, Kurella VB, McGuire AT, Stamatatos L, Hilbert BJ, Bohn MF, Kowalik TF, Jensen JD, Finberg RW, Wang JP, Goodall M, Jefferis R, Zhu Q, Kurt Yilmaz N, Schiffer CA, Marasco WA |
Cell Reports | 2017 |
The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia
J Wakim, E Arman, S Becker-Herman, MP Kramer, E Bakos, I Shachar, A Elson |
Oncogene | 2017 |
Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones
RJ Bashford-Rogers, AL Palser, C Hodkinson, J Baxter, GA Follows, GS Vassiliou, P Kellam |
Experimental Hematology | 2017 |
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations
R Rosenquist, P Ghia, A Hadzidimitriou, LA Sutton, A Agathangelidis, P Baliakas, N Darzentas, V Giudicelli, MP Lefranc, AW Langerak, C Belessi, F Davi, K Stamatopoulos |
Leukemia | 2017 |
Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment
P Ghia, B Nadel, B Sander, K Stamatopoulos, FK Stevenson |
Journal of Internal Medicine | 2017 |
State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia
H Mirzaei, S Fathullahzadeh, R Khanmohammadi, M Darijani, F Momeni, A Masoudifar, M Goodarzi, O Mardanshah, J Stenvang, MR Jaafari, HR Mirzaei |
Journal of Cellular Physiology | 2017 |
CD11c expression in chronic lymphocytic leukemia revisited, related with complications and survival
EG Umit, M Baysal, Y Durmus, AM Demir |
International Journal of Laboratory Hematology | 2017 |
Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification
LA Sutton, A Hadzidimitriou, P Baliakas, A Agathangelidis, AW Langerak, S Stilgenbauer, S Pospisilova, Z Davis, F Forconi, F Davi, P Ghia, R Rosenquist, K Stamatopoulos |
Haematologica | 2017 |
Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications
SJ Wu, CT Lin, A Agathangelidis, LI Lin, YY Kuo, HF Tien, P Ghia |
Haematologica | 2017 |
Lymphocyte Updates - Cancer, Autoimmunity and Infection
G Isvoranu |
Lymphocyte Updates - Cancer, Autoimmunity and Infection | 2017 |
Identification of key miRNA‑gene pairs in chronic lymphocytic leukemia through integrated analysis of mRNA and miRNA microarray
J Li, Y Qin, H Zhang |
Oncology Letters | 2017 |
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab
P Jain, GM González, R Kanagal-Shamanna, U Rozovski, N Sarwari, C Tam, WG Wierda, PA Thompson, N Jain, R Luthra, A Quesada, G Sanchez-Petitto, A Ferrajoli, J Burger, H Kantarjian, J Cortes, S O'Brien, MJ Keating, Z Estrov |
British Journal of Haematology | 2017 |
High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges
AW Langerak, M Brüggemann, F Davi, N Darzentas, JJ van Dongen, D Gonzalez, G Cazzaniga, V Giudicelli, MP Lefranc, M Giraud, EA Macintyre, M Hummel, C Pott, PJ Groenen, K Stamatopoulos |
Journal of immunology (Baltimore, Md. : 1950) | 2017 |
Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas
R Sklavenitis-Pistofidis, T Koletsa, A Lazaridou, A Goulas |
Forum of Clinical Oncology | 2017 |
Concurrent occurrence of two B chronic lymphoproliferative disorders—a rare phenomenon posing diagnostic dilemma for hematopathologist
A Gupta, S Bansal, R Sharma |
Journal of Hematopathology | 2017 |
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab
P Jain, GM González, R Kanagal-Shamanna, U Rozovski, N Sarwari, C Tam, WG Wierda, PA Thompson, N Jain, R Luthra, A Quesada, G Sanchez-Petitto, A Ferrajoli, J Burger, H Kantarjian, J Cortes, S O'Brien, MJ Keating, Z Estrov |
British Journal of Haematology | 2017 |
Structural Determination of the Broadly Reactive Anti- IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope
Y Avnir, KL Prachanronarong, Z Zhang, S Hou, EC Peterson, J Sui, H Zayed, VB Kurella, AT McGuire, L Stamatatos, BJ Hilbert, MF Bohn, TF Kowalik, JD Jensen, RW Finberg, JP Wang, M Goodall, R Jefferis, Q Zhu, NK Yilmaz, CA Schiffer, WA Marasco |
Cell Reports | 2017 |
Neoplastic Diseases of the Blood
PH Wiernik, JP Dutcher, MA Gertz |
2017 | |
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a non-classical Th1-dependent, Bcl-6-deficient process
Piers Patten, Gerardo Ferrer, Shih-Shih Chen, Rita Simone, Sonia Marsilio, Xiao-Jie Yan, Zachary Gitto, Chaohui Yuan, Jonathan Kolitz, Jacqueline Barrientos, Steven Allen, Kanti Rai, Thomas MacCarthy, Charles Chu, Nicholas Chiorazzi |
JCI Insight | 2016 |
Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL
DK Chang, VB Kurella, S Biswas, Y Avnir, J Sui, X Wang, J Sun, Y Wang, M Panditrao, E Peterson, A Tallarico, S Fernandes, M Goodall, Q Zhu, JR Brown, R Jefferis, WA Marasco |
mAbs | 2016 |
B Cell Anergy Modulated by TLR1/2 and the miR-17 92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4
S Ntoufa, N Papakonstantinou, B Apollonio, M Gounari, C Galigalidou, E Fonte, A Anagnostopoulos, C Belessi, M Muzio, P Ghia, K Stamatopoulos |
Journal of immunology (Baltimore, Md. : 1950) | 2016 |
Chronic lymphocytic leukemia immunoglobulins display broad bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation status
K Hatzi, R Catera, CM Atanasio, VA Fischetti, SL Allen, JE Kolitz, KR Rai, CC Chu, N Chiorazzi |
Clinical Immunology | 2016 |
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors
LA Sutton, E Young, P Baliakas, A Hadzidimitriou, T Moysiadis, K Plevova, D Rossi, J Kminkova, E Stalika, LB Pedersen, J Malcikova, A Agathangelidis, Z Davis, L Mansouri, L Scarfo, M Boudjoghra, A Navarro, AF Muggen, XJ Yan, F Nguyen-Khac, M Larrayoz, P Panagiotidis, N Chiorazzi, CU Niemann, C Belessi, E Campo, JC Strefford, AW Langerak, D Oscier, G Gaidano, S Pospisilova, F Davi, P Ghia, K Stamatopoulos, R Rosenquist |
Haematologica | 2016 |
Antigen receptor stereotypy in chronic lymphocytic leukemia
K Stamatopoulos, A Agathangelidis, R Rosenquist, P Ghia |
Leukemia | 2016 |
Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?
JC Allen, F Talab, JR Slupsky |
International Journal of Hematologic Oncology | 2016 |
IL-4 rescues surface IgM expression in chronic lymphocytic leukemia
B Guo, L Zhang, N Chiorazzi, TL Rothstein |
Blood | 2016 |
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
A Bresin, L D'Abundo, MG Narducci, MT Fiorenza, CM Croce, M Negrini, G Russo |
Cell Death and Disease | 2016 |
Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells
K Hayakawa, AM Formica, MJ Colombo, SA Shinton, J Brill-Dashoff, HC Morse, YS Li, RR Hardy |
Leukemia | 2016 |
Statistical inference of a convergent antibody repertoire response to influenza vaccine
NB Strauli, RD Hernandez |
Genome Medicine | 2016 |
Chronic lymphocytic leukemia (CLL)-Then and now: Chronic lymphocytic leukemia
KR Rai, P Jain |
American Journal of Hematology | 2016 |
Chronic lymphocytic leukaemia
L Scarfò, AJ Ferreri, P Ghia |
Critical Reviews in Oncology/Hematology | 2016 |
Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia
M Marinelli, C Ilari, Y Xia, ID Giudice, L Cafforio, ID Starza, S Raponi, P Mariglia, S Bonina, Z Yu, W Yang, L Qiu, T Chan, A Piciocchi, YL Kwong, E Tse, J Li, A Guarini, W Xu, R Foà |
Oncotarget | 2016 |
The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia
Y Li, S Hu, SA Wang, S Li, YO Huh, Z Tang, LJ Medeiros, G Tang |
Modern Pathology | 2016 |
Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia
L Rani, N Mathur, A Gogia, S Vishnubhatla, L Kumar, A Sharma, D Dube, P Kaur, R Gupta |
Leukemia & Lymphoma | 2016 |
El estado mutacional de las inmunoglobulinas en pacientes con leucemia linfocítica crónica: significado y pronóstico
SY Preciado, P Barros-Núñez |
Gaceta Mexicana de Oncología | 2016 |
Modeling the chronic lymphocytic leukemia microenvironment in vitro
K Crassini, Y Shen, S Mulligan, OG Best |
Leukemia & Lymphoma | 2016 |
Total proteome analysis identifies migration defects as a major pathogenetic factor in IGHV-unmutated chronic lymphocytic leukemia
GL Eagle, J Zhuang, RE Jenkins, KJ Till, PV Jithesh, K Lin, GG Johnson, M Oates, K Park, NR Kitteringham, AR Pettitt |
Molecular & cellular proteomics : MCP | 2015 |
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia
JS Blachly, AS Ruppert, W Zhao, S Long, J Flynn, I Flinn, J Jones, K Maddocks, L Andritsos, EM Ghia, LZ Rassenti, TJ Kipps, A la Chapelle, JC Byrd |
Proceedings of the National Academy of Sciences | 2015 |
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8
M Gounari, S Ntoufa, B Apollonio, N Papakonstantinou, M Ponzoni, CC Chu, D Rossi, G Gaidano, N Chiorazzi, K Stamatopoulos, P Ghia |
Blood | 2015 |
Restricted, canonical, stereotyped and convergent immunoglobulin responses
CJ Dunand, PC Wilson |
Philosophical Transactions of the Royal Society B: Biological Sciences | 2015 |
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
RM Young, T Wu, R Schmitz, M Dawood, W Xiao, JD Phelan, W Xu, L Menard, E Meffre, WC Chan, ES Jaffe, RD Gascoyne, E Campo, A Rosenwald, G Ott, J Delabie, LM Rimsza, LM Staudt |
Proceedings of the National Academy of Sciences | 2015 |
VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool
G Paciello, A Acquaviva, C Pighi, A Ferrarini, E Macii, A Zamo’, E Ficarra, Q Shi |
PloS one | 2015 |
The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia
LA Sutton, R Rosenquist |
Seminars in Cancer Biology | 2015 |
Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability
X Cui, L Zhang, AR Magli, R Catera, XJ Yan, DO Griffin, TL Rothstein, J Barrientos, JE Kolitz, SL Allen, KR Rai, N Chiorazzi, CC Chu |
Leukemia | 2015 |
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
S Martinelli, A Cuneo, GM Rigolin |
Mediterranean journal of hematology and infectious diseases | 2015 |
Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKC subversion induces up-regulation of PKC II expression in B lymphocytes
R Nakagawa, M Vukovic, A Tarafdar, E Cosimo, K Dunn, AM McCaig, A Holroyd, F McClanahan, AG Ramsay, JG Gribben, AM Michie |
Haematologica | 2015 |
Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells
CC Yin, G Tang, G Lu, X Feng, MJ Keating, LJ Medeiros, LV Abruzzo |
Modern Pathology | 2015 |
Current Topics in Microbiology and Immunology
K Okkenhaug, JA Burger |
Current topics in microbiology and immunology | 2015 |
Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia
RD Innis-Shelton, RS Davis, L Lamb, S Mineishi |
Leukemia & Lymphoma | 2015 |
Hypermorphic mutation of phospholipase C, 2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
TM Liu, JA Woyach, Y Zhong, A Lozanski, G Lozanski, S Dong, E Strattan, A Lehman, X Zhang, JA Jones, J Flynn, LA Andritsos, K Maddocks, SM Jaglowski, KA Blum, JC Byrd, JA Dubovsky, AJ Johnson |
Blood | 2015 |
Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia
S Yepes, MM Torres, L López-Kleine |
BMC Genomics | 2015 |
Do Biologic Parameters Affect the Time to First Treatment of Clinical Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia Rai Stage 0? Results of a Prospective Analysis
S Molica, D Giannarelli, L Levato, M Gentile, R Mirabelli, F Morabito |
Clinical Lymphoma Myeloma and Leukemia | 2015 |
High-Throughput Sequencing Using the Ion Torrent Personal Genome Machine for Clinical Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia
R McClure, M Mai, S McClure |
The Journal of Molecular Diagnostics | 2015 |
ASSOCIATION BETWEEN GENE AND MIRNA EXPRESSION PROFILES AND STEREOTYPED SUBSET #4 B-CELL RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA
F Maura, G Cutrona, L Mosca, S Matis, M Lionetti, S Fabris, L Agnelli, M Colombo, C Massucco, M Ferracin, B Zagatti, D Reverberi, M Gentile, AG Recchia, S Bossio, D Rossi, G Gaidano, S Molica, A Cortelezzi, FD Raimondo, M Negrini, P Tassone, F Morabito, M Ferrarini, A Neri |
Leukemia & Lymphoma | 2015 |
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model
S Molica, D Giannarelli, R Mirabelli, L Levato, A Russo, M Linardi, M Gentile, F Morabito |
European Journal of Haematology | 2015 |
Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle?
B Tandon, SH Swerdlow, RP Hasserjian, U Surti, SE Gibson |
Leukemia & Lymphoma | 2015 |
A new piece to the stereotypy ‘puzzle’ in chronic lymphocytic leukemia
R Rosenquist |
Leukemia & Lymphoma | 2015 |
Developing Molecular Signatures for Chronic Lymphocytic Leukemia
E Cornet, A Debliquis, V Rimelen, N Civic, M Docquier, X Troussard, B Drénou, T Matthes, M Baudis |
PloS one | 2015 |
Immunoglobulin gene expression in umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells
J Liu, M Xia, P Wang, C Wang, Z Geng, CC Yin, C Zhang, X Qiu |
Gene | 2015 |
Application of biomarkers in oncology clinical trials
N Dakappagari, H Gong, R Pollner, A Siva, S Tangri, J Lameh |
Clinical Investigation | 2015 |
SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients
T Mitsui, H Koiso, H Nakahashi, A Saitoh, H Shimizu, T Ishizaki, Y Ogawa, M Takizawa, A Yokohama, T Saitoh, T Jinbo, H Ogura, H Handa, M Sawamura, T Sakura, M Karasawa, H Murakami, Y Nojima, N Tsukamoto |
International Journal of Hematology | 2015 |
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
A Wiestner |
Haematologica | 2015 |
IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration.
Wang C, Xia M, Sun X, He Z, Hu F, Chen L, Bueso-Ramos CE, Qiu X, Yin CC |
Oncotarget | 2015 |
Dielectrophoretic isolation and detection of cancer-related circulating cell-free DNA biomarkers from blood and plasma: Nucleic acids
A Sonnenberg, JY Marciniak, EA Skowronski, S Manouchehri, L Rassenti, EM Ghia, GF Widhopf, TJ Kipps, MJ Heller |
Electrophoresis | 2014 |
Does B cell receptor signaling in chronic lymphocytic leukaemia cells differ from that in other B cell types?
JR Slupsky |
Scientifica | 2014 |
In vitro induction of antibody secretion of primary B-cell chronic lymphocytic leukaemia cells
R Hoogeboom, RJ Reinten, JJ Schot, JE Guikema, RJ Bende, CJ van Noesel |
Leukemia | 2014 |
Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study
SE Herman, CU Niemann, M Farooqui, J Jones, RZ Mustafa, A Lipsky, N Saba, S Martyr, S Soto, J Valdez, JA Gyamfi, I Maric, KR Calvo, LB Pedersen, CH Geisler, D Liu, GE Marti, G Aue, A Wiestner |
Leukemia | 2014 |
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria
KK Hwang, AM Trama, DM Kozink, X Chen, K Wiehe, AJ Cooper, SM Xia, M Wang, DJ Marshall, J Whitesides, M Alam, GD Tomaras, SL Allen, KR Rai, J McKeating, R Catera, XJ Yan, CC Chu, G Kelsoe, HX Liao, N Chiorazzi, BF Haynes |
PloS one | 2014 |
Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality
Ghaleb Elyamany, Kamal Fadalla, Hatem Elghezal, Omar Alsuhaibani, Hani Osman, Abdulaziz Al-Abulaaly |
Clinical Medicine Insights. Pathology | 2014 |
Immunoglobulin gene repertoire diversification and selection in the stomach - from gastritis to gastric lymphomas
M Michaeli, H Tabibian-Keissar, G Schiby, G Shahaf, Y Pickman, L Hazanov, K Rosenblatt, DK Dunn-Walters, I Barshack, R Mehr |
Frontiers in immunology | 2014 |
Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy
A Duckworth, M Glenn, JR Slupsky, G Packham, N Kalakonda |
Blood | 2014 |
Comprehensive characterization of immunoglobulin gene rearrangements in patients with chronic lymphocytic leukaemia
C René, N Prat, A Thuizat, M Broctawik, O Avinens, JF Eliaou |
Journal of Cellular and Molecular Medicine | 2014 |
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)
S Molica, D Giannarelli, L Levato, R Mirabelli, M Gentile, M Lentini, F Morabito |
International Journal of Hematology | 2014 |
The meaning and relevance of B-cell receptor structure and function in CLL
FK Stevenson, F Forconi, G Packham |
Seminars in Hematology | 2014 |
Cryptic polyreactivity of IgG expressed by splenic marginal zone B-cell lymphoma
A Mahendra, B Gangadharan, S André, M Boudjoghra, F Davi, M Lecerf, C Planchais, SV Kaveri, S Lacroix-Desmazes, JD Dimitrov |
Molecular Immunology | 2014 |
Stereotyped B-cell receptors in chronic lymphocytic leukemia
A Agathangelidis, A Vardi, P Baliakas, K Stamatopoulos |
Leukemia & Lymphoma | 2014 |
Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia
J Ojha, J Ayres, C Secreto, R Tschumper, K Rabe, DV Dyke, S Slager, T Shanafelt, R Fonseca, NE Kay, E Braggio |
Blood | 2014 |
BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma
A Wiestner |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2014 |
The biology behind PI3K inhibition in chronic lymphocytic leukaemia
V Ortiz-Maldonado, M Garcia-Morillo, J Delgado |
Therapeutic Advances in Hematology | 2014 |
The B-cell Receptor Pathway: A Critical Component of Healthy and Malignant Immune Biology
Y Zhong, JC Byrd, JA Dubovsky |
Seminars in Hematology | 2014 |
Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays
F Pauly, KE Smedby, M Jerkeman, H Hjalgrim, M Ohlsson, R Rosenquist, CA Borrebaeck, C Wingren |
Leukemia Research | 2014 |
Frequency analysis of HLA class I alleles in Iranian patients with progressive and non-progressive chronic lymphocytic leukemia
M Hojjat-Farsangi, SM Razavi, RA Sharifian, F Shokri |
Human Immunology | 2014 |
Immune control of Staphylococcus aureus – Regulation and counter-regulation of the adaptive immune response
BM Bröker, S Holtfreter, I Bekeredjian-Ding |
International Journal of Medical Microbiology | 2014 |
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications
M Lionetti, S Fabris, G Cutrona, L Agnelli, C Ciardullo, S Matis, G Ciceri, M Colombo, F Maura, L Mosca, M Gentile, AG Recchia, F Ilariucci, C Musolino, S Molica, FD Raimondo, A Cortelezzi, D Rossi, G Gaidano, F Morabito, M Ferrarini, A Neri |
British Journal of Haematology | 2014 |
Autoimmune cytopenias in chronic lymphocytic leukemia: Autoimmune Cytopenias in CLL
C Visco, W Barcellini, F Maura, A Neri, A Cortelezzi, F Rodeghiero |
American Journal of Hematology | 2014 |
Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines
S Molica, D Giannarelli, R Mirabelli, L Levato, M Gentile, M Lentini, F Morabito |
Expert Review of Hematology | 2014 |
IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria
KK Hwang, AM Trama, DM Kozink, X Chen, K Wiehe, AJ Cooper, SM Xia, M Wang, DJ Marshall, J Whitesides, M Alam, GD Tomaras, SL Allen, KR Rai, J McKeating, R Catera, XJ Yan, CC Chu, G Kelsoe, HX Liao, N Chiorazzi, BF Haynes, S Lu |
PloS one | 2014 |
Heterogeneous Functional Effects of Concomitant B Cell Receptor and TLR Stimulation in Chronic Lymphocytic Leukemia with Mutated versus Unmutated Ig Genes
M Chatzouli, S Ntoufa, N Papakonstantinou, E Chartomatsidou, A Anagnostopoulos, P Kollia, P Ghia, M Muzio, K Stamatopoulos, C Belessi |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling
SS Chen, F Batliwalla, NE Holodick, XJ Yan, S Yancopoulos, CM Croce, TL Rothstein, N Chiorazzi |
Proceedings of the National Academy of Sciences | 2013 |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Advances in Chronic Lymphocytic Leukemia
S Malek |
2013 | |
Targeting pathological B cell receptor signalling in lymphoid malignancies
RM Young, LM Staudt |
Nature Reviews Drug Discovery | 2013 |
Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence
LA Sutton, E Kostareli, E Stalika, A Tsaftaris, A Anagnostopoulos, N Darzentas, R Rosenquist, K Stamatopoulos |
Molecular Medicine | 2013 |
A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi
R Hoogeboom, KP van Kessel, F Hochstenbach, TA Wormhoudt, RJ Reinten, K Wagner, AP Kater, JE Guikema, RJ Bende, CJ van Noesel |
Journal of Experimental Medicine | 2013 |
Chronic Lymphocytic Leukemia Monitoring with a Lamprey Idiotope-Specific Antibody
H Nakahara, BR Herrin, MN Alder, R Catera, XJ Yan, N Chiorazzi, MD Cooper |
Cancer immunology research | 2013 |
Peptides That Bind Specifically to an Antibody from a Chronic Lymphocytic Leukemia Clone Expressing Unmutated Immunoglobulin Variable Region Genes
Y Liu, CD Higgins, CM Overstreet, KR Rai, N Chiorazzi, JR Lai |
Molecular Medicine | 2013 |
Igs Expressed by Chronic Lymphocytic Leukemia B Cells Show Limited Binding-Site Structure Variability
P Marcatili, F Ghiotto, C Tenca, A Chailyan, AN Mazzarello, XJ Yan, M Colombo, E Albesiano, D Bagnara, G Cutrona, F Morabito, S Bruno, M Ferrarini, N Chiorazzi, A Tramontano, F Fais |
Journal of immunology (Baltimore, Md. : 1950) | 2013 |
B cell receptor signaling in chronic lymphocytic leukemia
JA Burger, N Chiorazzi |
Trends in Immunology | 2013 |
Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications
Y Herishanu, BZ Katz, A Lipsky, A Wiestner |
Hematology/Oncology Clinics of North America | 2013 |
Modeling tumor–host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy
SE Herman, X Sun, EM McAuley, MM Hsieh, S Pittaluga, M Raffeld, D Liu, K Keyvanfar, CM Chapman, J Chen, JJ Buggy, G Aue, JF Tisdale, P Pérez-Galán, A Wiestner |
Leukemia | 2013 |
The pathogenesis of chronic lymphocytic leukemia
S Zhang, TJ Kipps |
Annual review of pathology | 2013 |
Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells
C Zwick, N Fadle, E Regitz, M Kemele, S Stilgenbauer, A Buhler, M Pfreundschuh, KD Preuss |
Blood | 2013 |
IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope
X Que, GF 2nd, S Amir, K Hartvigsen, LF Hansen, D Woelkers, S Tsimikas, CJ Binder, TJ Kipps, JL Witztum |
PloS one | 2013 |
Chronic lymphocytic leukemia with t(14;18)(q32;q21)
G Tang, HE Banks, RL Sargent, LJ Medeiros, LV Abruzzo |
Human Pathology | 2013 |
Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
S Zhang, CC Wu, JF Fecteau, B Cui, L Chen, L Zhang, R Wu, L Rassenti, F Lao, S Weigand, TJ Kipps |
Proceedings of the National Academy of Sciences | 2013 |
Molecular analysis of immunoglobulin genes reveals frequent clonal relatedness in double monoclonal gammopathies
RC Tschumper, A Dispenzieri, RS Abraham, KJ Henderson, DF Jelinek |
Blood Cancer Journal | 2013 |
Hepatic Manifestations in Hematological Disorders
J Murakami, Y Shimizu |
International Journal of Hepatology | 2013 |
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy
C Pighi, S Barbi, A Bertolaso, A Zamò |
Leukemia & Lymphoma | 2013 |
The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal
P Baliakas, G Kanellis, N Stavroyianni, M Fameli, A Anagnostopoulos, K Stamatopoulos, T Papadaki |
Leukemia & Lymphoma | 2013 |
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: Results of a comparative analysis
S Molica, D Giannarelli, M Gentile, G Cutrona, ND Renzo, FD Raimondo, A Neri, M Federico, M Ferrarini, F Morabito |
Leukemia Research | 2013 |
The Significance of Stereotyped B-Cell Receptors in Chronic Lymphocytic Leukemia
N Darzentas, K Stamatopoulos |
Hematology/Oncology Clinics of North America | 2013 |
The changing paradigm of CLL management
C Lobetti-Bodoni, F Bertoni, G Stussi, F Cavalli, E Zucca |
European Journal of Internal Medicine | 2013 |
Immunoglobulin Gene Rearrangements and Mutational Status in Argentinian Patients With Chronic Lymphocytic Leukemia
C Stanganelli, A Travella, R Bezares, I Slavutsky |
Clinical Lymphoma Myeloma and Leukemia | 2013 |
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2
JC Strefford, LA Sutton, P Baliakas, A Agathangelidis, J Malčíková, K Plevova, L Scarfó, Z Davis, E Stalika, D Cortese, N Cahill, LB Pedersen, PF di Celle, T Tzenou, C Geisler, P Panagiotidis, AW Langerak, N Chiorazzi, S Pospisilova, D Oscier, F Davi, C Belessi, L Mansouri, P Ghia, K Stamatopoulos, R Rosenquist |
Leukemia | 2013 |
Non-Hodgkin Lymphomas: Advanced Diagnostics & Personalized Therapies
SA Pileri, C Agostinelli, E Sabattini, F Bacci, C Sagramoso, A Pileri, B Falini, PP Piccaluga |
Non-Hodgkin Lymphomas: Advanced Diagnostics & Personalized Therapies | 2013 |
ANTIGEN SELECTION IN B-CELL LYMPHOMAS–TRACING THE EVIDENCE
LA Sutton, A Agathangelidis, C Belessi, N Darzentas, F Davi, P Ghia, R Rosenquist, K Stamatopoulos |
Seminars in Cancer Biology | 2013 |
Monoclonal B cell lymphocytosis and “in situ” lymphoma
K Karube, L Scarfò, E Campo, P Ghia |
Seminars in Cancer Biology | 2013 |
B-cell receptor signaling as a driver of lymphoma development and evolution
CU Niemann, A Wiestner |
Seminars in Cancer Biology | 2013 |
Rearrangement and expression of the immunoglobulin μ-chain gene in human myeloid cells
J Huang, X Sun, X Gong, Z He, L Chen, X Qiu, CC Yin |
Cellular and Molecular Immunology | 2013 |
Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry: Prognostic Value Of Zap-70 In Cll By Qpcr And Fcm
RL Adams, C Cheung, R Banh, R Saal, D Cross, D Gill, M Self, K Klein, P Mollee |
Cytometry Part B Clinical Cytometry | 2013 |
Ibrutinib for the treatment of chronic lymphocytic leukemia
MZ Farooqui, A Wiestner |
Expert Opinion on Orphan Drugs | 2013 |
Rapid Electrokinetic Isolation of Cancer-Related Circulating Cell-Free DNA Directly from Blood
A Sonnenberg, JY Marciniak, L Rassenti, EM Ghia, EA Skowronski, S Manouchehri, J McCanna, GF Widhopf, TJ Kipps, MJ Heller |
Clinical chemistry | 2013 |
Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies
A Wiestner |
Journal of Clinical Oncology | 2013 |
IGHV1-69-Encoded Antibodies Expressed in Chronic Lymphocytic Leukemia React with Malondialdehyde–Acetaldehyde Adduct, an Immunodominant Oxidation-Specific Epitope
X Que, GF Widhopf, S Amir, K Hartvigsen, LF Hansen, D Woelkers, S Tsimikas, CJ Binder, TJ Kipps, JL Witztum, D Fang |
PloS one | 2013 |
Prognostic value of ZAP-70 expression in chronic lymphocytic leukaemia as assessed by quantitative polymerase chain reaction and flow cytometry: Prognostic Value of ZAP-70 in CLL by qPCR and FCM
RL Adams, C Cheung, R Banh, R Saal, D Cross, D Gill, M Self, K Klein, P Mollee |
Cytometry Part B Clinical Cytometry | 2013 |
Differential microRNA Profiles and Their Functional Implications in Different Immunogenetic Subsets of Chronic Lymphocytic Leukemia
N Papakonstantinou, S Ntoufa, E Chartomatsidou, G Papadopoulos, A Hatzigeorgiou, A Anagnostopoulos, K Chlichlia, P Ghia, M Muzio, C Belessi, K Stamatopoulos |
Molecular Medicine | 2013 |
Non-coding RNAs and Cancer
M Fabbri |
2013 | |
Temporal Dynamics of Clonal Evolution in Chronic Lymphocytic Leukemia with Stereotyped IGHV4-34/IGKV2-30 Antigen Receptors: Longitudinal Immunogenetic Evidence
LA Sutton, E Kostareli, E Stalika, A Tsaftaris, A Anagnostopoulos, N Darzentas, R Rosenquist, K Stamatopoulos |
Molecular Medicine | 2013 |
Expression of immunoglobulin receptors with distinctive features indicating antigen selection by marginal zone B cells from human spleen.
Colombo M, Cutrona G, Reverberi D, Bruno S, Ghiotto F, Tenca C, Stamatopoulos K, Hadzidimitriou A, Ceccarelli J, Salvi S, Boccardo S, Calevo MG, De Santanna A, Truini M, Fais F, Ferrarini M |
Molecular Medicine | 2013 |
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions
PE Patten, CC Chu, E Albesiano, RN Damle, XJ Yan, D Kim, L Zhang, AR Magli, J Barrientos, JE Kolitz, SL Allen, KR Rai, S Roa, PK Mongini, T MacCarthy, MD Scharff, N Chiorazzi |
Blood | 2012 |
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia
R Claus, DM Lucas, S Stilgenbauer, AS Ruppert, L Yu, M Zucknick, D Mertens, A Bühler, CC Oakes, RA Larson, NE Kay, DF Jelinek, TJ Kipps, LZ Rassenti, JG Gribben, H Döhner, NA Heerema, G Marcucci, C Plass, JC Byrd |
Journal of Clinical Oncology | 2012 |
Pathogenesis of Human B Cell Lymphomas
AL Shaffer, RM Young, LM Staudt |
Annual Review of Immunology | 2012 |
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
A Agathangelidis, N Darzentas, A Hadzidimitriou, X Brochet, F Murray, XJ Yan, Z Davis, EJ van Gastel-Mol, C Tresoldi, CC Chu, N Cahill, V Giudicelli, B Tichy, LB Pedersen, L Foroni, L Bonello, A Janus, K Smedby, A Anagnostopoulos, H Merle-Beral, N Laoutaris, G Juliusson, PF di Celle, S Pospisilova, J Jurlander, C Geisler, A Tsaftaris, MP Lefranc, AW Langerak, DG Oscier, N Chiorazzi, C Belessi, F Davi, R Rosenquist, P Ghia, K Stamatopoulos |
Blood | 2012 |
Immunoglobulin gene repertoire in chronic lymphocytic leukemia: insight into antigen selection and microenvironmental interactions
E Kostareli, M Gounari, A Agathangelidis, K Stamatopoulos |
Mediterranean journal of hematology and infectious diseases | 2012 |
Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors
S Ntoufa, A Vardi, N Papakonstantinou, A Anagnostopoulos, V Aleporou-Marinou, C Belessi, P Ghia, F Caligaris-Cappio, M Muzio, K Stamatopoulos |
Molecular Medicine | 2012 |
Lymphoma
R Küppers |
Lymphoma | 2012 |
Lymphoma
R Küppers |
Lymphoma | 2012 |
Lymphoma
R Küppers |
Lymphoma | 2012 |
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients
RN Damle, S Temburni, T Banapour, S Paul, PK Mongini, SL Allen, JE Kolitz, KR Rai, N Chiorazzi |
Blood | 2012 |
Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L
M Cols, CM Barra, B He, I Puga, W Xu, A Chiu, W Tam, DM Knowles, SR Dillon, JP Leonard, RR Furman, K Chen, A Cerutti |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes
S Ferrero, D Capello, M Svaldi, M Boi, D Gatti, D Drandi, D Rossi, S Barbiero, B Mantoan, E Mantella, M Zanni, P Ghione, A Larocca, R Passera, F Bertoni, V Gattei, F Forconi, L Laurenti, GD Poeta, R Marasca, S Cortelazzo, G Gaidano, A Palumbo, M Boccadoro, M Ladetto |
Haematologica | 2012 |
Association of Interleukin-6 and Interleukin-8 with Poor Prognosis in Elderly Chronic Lymphocytic Leukemia Patients
JY Yoon, S Lafarge, D Dawe, S Lakhi, R Kumar, C Morales, A Marshall, SB Gibson, JB Johnston |
Leukemia and Lymphoma | 2012 |
Through a glass less darkly: apoptosis and the germinal center response to antigen : Apoptosis and the GC response to antigen
V Peperzak, IB Vikstrom, DM Tarlinton |
Immunological Reviews | 2012 |
Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia
MT Scupoli, G Pizzolo |
Expert Review of Hematology | 2012 |
Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain V-D-J Intraclonal Variation Using Massively Parallel Pyrosequencing
RC Tschumper, YW Asmann, A Hossain, PM Huddleston, X Wu, A Dispenzieri, BW Eckloff, DF Jelinek |
Oncotarget | 2012 |
Mutational Status and Gene Repertoire of IGHV-IGHD-IGHJ Rearrangements in Serbian Patients With Chronic Lymphocytic Leukemia
T Karan-Djurasevic, V Palibrk, T Kostic, V Spasovski, G Nikcevic, S Srzentic, M Colovic, N Colovic, A Vidovic, D Antic, B Mihaljevic, S Pavlovic, N Tosic |
Clinical Lymphoma Myeloma and Leukemia | 2012 |
Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression
HY Chuang, L Rassenti, M Salcedo, K Licon, A Kohlmann, T Haferlach, R Foa, T Ideker, TJ Kipps |
Blood | 2012 |
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia
S Fabris, L Mosca, G Cutrona, M Lionetti, L Agnelli, G Ciceri, M Barbieri, F Maura, S Matis, M Colombo, M Gentile, AG Recchia, EA Pesce, FD Raimondo, C Musolino, M Gobbi, ND Renzo, FR Mauro, M Brugiatelli, F Ilariucci, MG Lipari, F Angrilli, U Consoli, A Fragasso, S Molica, G Festini, I Vincelli, A Cortelezzi, M Federico, F Morabito, M Ferrarini, A Neri |
American Journal of Hematology | 2012 |
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia
F Maura, C Visco, E Falisi, G Reda, S Fabris, L Agnelli, G Tuana, M Lionetti, N Guercini, E Novella, I Nichele, A Montaldi, F Autore, A Gregorini, W Barcellini, V Callea, FR Mauro, L Laurenti, R Foà, A Neri, F Rodeghiero, A Cortelezzi |
American Journal of Hematology | 2012 |
Geography, ethnicity and “roots” in chronic lymphocytic leukemia
R Ruchlemer, A Polliack |
Leukemia & Lymphoma | 2012 |
Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies
LQ Wang, R Liang, CS Chim |
Expert Review of Molecular Diagnostics | 2012 |
Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia
X Qiu, X Sun, Z He, J Huang, F Hu, L Chen, P Lin, MJ You, LJ Medeiros, CC Yin |
Leukemia | 2012 |
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia
S Molica, D Giannarelli, M Gentile, G Cutrona, ND Renzo, FD Raimondo, A Neri, M Federico, M Ferrrarini, F Morabito |
Cancer | 2012 |
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia
A Wiestner |
Blood | 2012 |
Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics
J Tao, E Sotomayor |
2012 | |
Molecular Aspects of Hematologic Malignancies
M Witt, M Dawidowska, T Szczepanski |
2012 | |
Implications of new prognostic markers in chronic lymphocytic leukemia
N Chiorazzi |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2012 |
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia
A Wiestner |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2012 |
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease
D Bagnara, MS Kaufman, C Calissano, S Marsilio, PE Patten, R Simone, P Chum, XJ Yan, SL Allen, JE Kolitz, S Baskar, C Rader, H Mellstedt, H Rabbani, A Lee, PK Gregersen, KR Rai, N Chiorazzi |
Blood | 2011 |
Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia
M Colombo, G Cutrona, D Reverberi, S Fabris, A Neri, M Fabbi, G Quintana, G Quarta, F Ghiotto, F Fais, M Ferrarini |
Molecular Medicine | 2011 |
Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells
KK Hwang, X Chen, DM Kozink, M Gustilo, DJ Marshall, JF Whitesides, HX Liao, R Catera, CC Chu, XJ Yan, MA Luftig, BF Haynes, N Chiorazzi |
Blood | 2011 |
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities
N Chiorazzi, M Ferrarini |
Blood | 2011 |
Torque Teno Virus 10 Isolated by Genome Amplification Techniques from a Patient with Concomitant Chronic Lymphocytic Leukemia and Polycythemia Vera
CC Chu, L Zhang, A Dhayalan, BM Agagnina, AR Magli, G Fraher, S Didier, LP Johnson, WJ Kennedy, RN Damle, XJ Yan, PE Patten, S Teichberg, P Koduru, JE Kolitz, SL Allen, KR Rai, N Chiorazzi |
Molecular Medicine | 2011 |
Immunologic aspects of monoclonal B cell lymphocytosis
MC Lanasa, JB Weinberg |
Immunologic Research | 2011 |
A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia
A Perrot, C Pionneau, S Nadaud, F Davi, V Leblond, F Jacob, H Merle-Beral, R Herbrecht, MC Bene, JG Gribben, S Bahram, L Vallat |
Blood | 2011 |
Malignant pirates of the immune system
L Rui, R Schmitz, M Ceribelli, LM Staudt |
Nature Immunology | 2011 |
Partial versus Productive Immunoglobulin Heavy Locus Rearrangements in Chronic Lymphocytic Leukemia: Implications for B-Cell Receptor Stereotypy
E Tsakou, A Agathagelidis, M Boudjoghra, T Raff, A Dagklis, M Chatzouli, T Smilevska, G Bourikas, H Merle-Beral, E Manioudaki-Kavallieratou, A Anagnostopoulos, M Brüggemann, F Davi, K Stamatopoulos, C Belessi |
Molecular Medicine | 2011 |
Advances in Malignant Hematology
KH Shain, AF List, RS Komrokji |
Advances in Malignant Hematology | 2011 |
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné |
Advances in Immunology Volume 110 | 2011 |
Detection methods of ZAP-70 in chronic lymphocytic leukemia
YH Wang, L Fan, W Xu, JY Li |
Clinical and Experimental Medicine | 2011 |
Immunoglobulin class switch recombination in chronic lymphocytic leukemia
MC Lanasa, JB Weinberg |
Leukemia & Lymphoma | 2011 |
New insights into the pathobiology of chronic lymphocytic leukemia
R Gunnarsson, R Rosenquist |
Journal of Hematopathology | 2011 |
Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia
Y Kikushige, F Ishikawa, T Miyamoto, T Shima, S Urata, G Yoshimoto, Y Mori, T Iino, T Yamauchi, T Eto, H Niiro, H Iwasaki, K Takenaka, K Akashi |
Cancer Cell | 2011 |
Phase II Study of Cenersen, an Antisense Inhibitor of p53, in Combination with Fludarabine, Cyclophosphamide, and Rituximab for High Risk CLL
MC Lanasa, PH Davis, M Datto, Z Li, JP Gockerman, JO Moore, CM DeCastro, DR Friedman, LF Diehl, C Rehder, H Cook, FJ Daugherty, KM Matta, JB Weinberg, D Rizzieri |
Leukemia & Lymphoma | 2011 |
Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia
TJ Hamblin |
Leukemia Research | 2011 |
MicroRNAs in chronic lymphocytic leukemia
BP Ward, GJ Tsongalis, P Kaur |
Experimental and Molecular Pathology | 2011 |
Personalizing treatment for chronic lymphocytic leukemia
P Abrisqueta, M Crespo, F Bosch |
Expert Review of Hematology | 2011 |
The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis
V Válková, J Schwarz, A Vítek, M Marková, D Pohlreich, K Benešová, K Michalová, P Cetkovský, M Trněný |
Hematological Oncology | 2011 |
High prevalence of adverse prognostic genetic aberrations and unmutated IGHV genes in small lymphocytic lymphoma as compared to chronic lymphocytic leukemia
PJ Groenen, R Raymakers, PD Rombout, M Prenter, L Kossen, C Philipsen-Jansen, T Feuth, JW Meijer, AG Kessel, JH Krieken, M Stevens-Kroef |
Journal of Hematopathology | 2011 |
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage
M Dal-Bo, ID Giudice, R Bomben, D Capello, F Bertoni, F Forconi, L Laurenti, D Rossi, A Zucchetto, G Pozzato, R Marasca, DG Efremov, A Guarini, GD Poeta, R Foà, G Gaidano, V Gattei |
British Journal of Haematology | 2011 |
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
XJ Yan, I Dozmorov, W Li, S Yancopoulos, C Sison, M Centola, P Jain, SL Allen, JE Kolitz, KR Rai, N Chiorazzi, B Sherry |
Blood | 2011 |
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia
F Morabito, RD Filippi, L Laurenti, K Zirlik, AG Recchia, M Gentile, E Morelli, E Vigna, V Gigliotti, R Calemma, B Amoroso, A Neri, G Cutrona, M Ferrarini, S Molica, GD Poeta, C Tripodo, A Pinto |
Blood | 2011 |
Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation
A Dagklis, M Ponzoni, S Govi, MG Cangi, E Pasini, F Charlotte, A Vino, C Doglioni, F Davì, IS Lossos, I Ntountas, T Papadaki, R Dolcetti, AJ Ferreri, K Stamatopoulos, P Ghia |
Leukemia | 2011 |
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken |
Advances in Cancer Research Volume 110 | 2011 |
Analysis of <i>p53</i> Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia
M Isin, M Yenerel, M Aktan, N Buyru, N Dalay |
DNA and Cell Biology | 2011 |
Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of Chronic Lymphocytic Leukemia
F Maura, G Cutrona, S Fabris, M Colombo, G Tuana, L Agnelli, S Matis, M Lionetti, M Gentile, AG Recchia, FD Raimondo, C Musolino, F Ilariucci, ND Renzo, E Pesce, S Molica, M Federico, A Cortelezzi, F Morabito, M Ferrarini, A Neri |
PloS one | 2011 |
Immnuophenotypic and Gene Expression Analysis of Monoclonal B Cell Lymphocytosis Shows Biologic Characteristics Associated With Good Prognosis CLL
MC Lanasa, SD Allgood, SL Slager, SS Dave, C Love, GE Marti, NE Kay, CA Hanson, KG Rabe, SJ Achenbach, LR Goldin, NJ Camp, BK Goodman, CM Vachon, LG Spector, LZ Rassenti, JF Leis, JP Gockerman, SS Strom, TG Call, M Glenn, JR Cerhan, MC Levesque, JB Weinberg, NE Caporaso |
Leukemia | 2011 |
A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia
CD Schweighofer, KR Coombes, LL Barron, L Diao, RJ Newman, A Ferrajoli, S O'Brien, WG Wierda, R Luthra, LJ Medeiros, MJ Keating, LV Abruzzo |
PloS one | 2011 |
Mutation Pattern of Paired Immunoglobulin Heavy and Light Variable Domains in Chronic Lymphocytic Leukemia B Cells
F Ghiotto, P Marcatili, C Tenca, MG Calevo, XJ Yan, E Albesiano, D Bagnara, M Colombo, G Cutrona, CC Chu, F Morabito, S Bruno, M Ferrarini, A Tramontano, F Fais, N Chiorazzi |
Molecular Medicine | 2011 |
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients
H Duzkale, CD Schweighofer, KR Coombes, LL Barron, A Ferrajoli, S O'Brien, WG Wierda, J Pfeifer, T Majewski, BA Czerniak, JL Jorgensen, LJ Medeiros, EJ Freireich, MJ Keating, LV Abruzzo |
Blood | 2011 |
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches
RE Hayden, G Pratt, C Roberts, MT Drayson, CM Bunce |
Leukemia & Lymphoma | 2011 |
Update on Therapy of Chronic Lymphocytic Leukemia
JG Gribben, S O'Brien |
Journal of Clinical Oncology | 2011 |
Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of Chronic Lymphocytic Leukemia
F Maura, G Cutrona, S Fabris, M Colombo, G Tuana, L Agnelli, S Matis, M Lionetti, M Gentile, AG Recchia, FD Raimondo, C Musolino, F Ilariucci, ND Renzo, E Pesce, S Molica, M Federico, A Cortelezzi, F Morabito, M Ferrarini, A Neri, C Bunce |
PloS one | 2011 |
A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia
CD Schweighofer, KR Coombes, LL Barron, L Diao, RJ Newman, A Ferrajoli, S O'Brien, WG Wierda, R Luthra, LJ Medeiros, MJ Keating, LV Abruzzo, A Navarro |
PloS one | 2011 |
Relevance of IgVH Gene Somatic Hypermutation and Interphase Cytogenetics in Lymphomatous Presentation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
CC Yeung, ML Powers, TD Nguyen, F Kreisel, JL Frater, BA Zehnbauer, R Burack, A Hassan |
International Journal of Surgical Pathology | 2011 |
Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells
M Binder, B Léchenne, R Ummanni, C Scharf, S Balabanov, M Trusch, H Schlüter, I Braren, E Spillner, M Trepel |
PloS one | 2010 |
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
M Marincevic, M Mansouri, M Kanduri, A Isaksson, H Göransson, KE Smedby, J Jurlander, G Juliusson, F Davi, K Stamatopoulos, R Rosenquist |
Haematologica | 2010 |
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
M Marincevic, N Cahill, R Gunnarsson, A Isaksson, M Mansouri, H Göransson, M Rasmussen, M Jansson, F Ryan, K Karlsson, HO Adami, F Davi, J Jurlander, G Juliusson, K Stamatopoulos, R Rosenquist |
Haematologica | 2010 |
Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution
E Kostareli, LA Sutton, A Hadzidimitriou, N Darzentas, A Kouvatsi, A Tsaftaris, A Anagnostopoulos, R Rosenquist, K Stamatopoulos |
Leukemia | 2010 |
Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells
RN Damle, C Calissano, N Chiorazzi |
Best Practice & Research Clinical Haematology | 2010 |
Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering
JM Tromp, SH Tonino, JA Elias, A Jaspers, DM Luijks, AP Kater, RA van Lier, MH van Oers, E Eldering |
Oncogene | 2010 |
B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia
M Binder, F Müller, A Jackst, B Léchenne, M Pantic, U Bacher, C Eulenburg, H Veelken, R Mertelsmann, R Pasqualini, W Arap, M Trepel |
Cancer | 2010 |
Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome
PJ Guire, C Cunningham-Rundles, H Ochs, GA Diaz |
Clinical Immunology | 2010 |
Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
CI Chen, PL Bergsagel, H Paul, W Xu, A Lau, N Dave, V Kukreti, E Wei, C Leung-Hagesteijn, ZH Li, J Brandwein, M Pantoja, J Johnston, S Gibson, T Hernandez, D Spaner, S Trudel |
Journal of Clinical Oncology | 2010 |
Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments
M Perez, A Pacchiarotti, M Frontani, E Pescarmona, E Caprini, GA Lombardo, G Russo, T Faraggiana |
British Journal of Dermatology | 2010 |
Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort
N Bilous, R Bomben, MD Bo, D Capello, F Forconi, L Laurenti, F Bertoni, DG Efremov, R Marasca, GD Poeta, Z Martina, I Kryachouk, I Dyagil, G Gaidano, A Chumak, V Gattei, I Abramenko |
Leukemia & Lymphoma | 2010 |
Antigens in chronic lymphocytic leukemia—Implications for cell origin and leukemogenesis
A Rosén, F Murray, C Evaldsson, R Rosenquist |
Seminars in Cancer Biology | 2010 |
Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression
JH Admirand, RJ Knoblock, KR Coombes, C Tam, EJ Schlette, WG Wierda, A Ferrajoli, S O'Brien, MJ Keating, R Luthra, LJ Medeiros, LV Abruzzo |
Modern Pathology | 2010 |
Polymerase chain reaction (PCR) detection of B cell clonality in Sjögren's syndrome patients: a diagnostic tool of clonal expansion
LM Guzmán, D Castillo, SO Aguilera |
Clinical & Experimental Immunology | 2010 |
Immunoglobulin heavy chain V-D-J gene rearrangement and mutational status in Uruguayan patients with chronic lymphocytic leukemia
S Bianchi, P Moreno, AI Landoni, H Naya, P Oppezzo, G Dighiero, R Gabús, O Pritsch |
Leukemia & Lymphoma | 2010 |
Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia
F Marantidou, A Dagklis, E Stalika, P Korkolopoulou, A Saetta, A Anagnostopoulos, N Laoutaris, K Stamatopoulos, C Belessi, Z Scouras, E Patsouris |
Blood Cells, Molecules, and Diseases | 2010 |
Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutatedIGHgene, and indolent clinical behavior
J Tomomatsu, Y Isobe, K Oshimi, Y Tabe, K Ishii, M Noguchi, T Hirano, N Komatsu, K Sugimoto |
Leukemia & Lymphoma | 2010 |
Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: Pathogenic and clinical implications
R Dolcetti, AD Rossi |
Medicinal Research Reviews | 2010 |
Genetic variation and risk of chronic lymphocytic leukaemia
D Crowther-Swanepoel, RS Houlston |
Seminars in Cancer Biology | 2010 |
New insights into the pathogenesis of chronic lymphocytic leukemia
U Klein, R Dalla-Favera |
Seminars in Cancer Biology | 2010 |
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
T Zenz, S Fröhling, D Mertens, H Döhner, S Stilgenbauer |
Best Practice & Research Clinical Haematology | 2010 |
The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy
CD Schweighofer, YO Huh, R Luthra, RL Sargent, RP Ketterling, RA Knudson, LL Barron, LJ Medeiros, MJ Keating, LV Abruzzo |
International Journal of Cancer | 2010 |
Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia
L Weiss, T Melchardt, A Egle, C Grabmer, R Greil, I Tinhofer |
Cancer | 2010 |
Novel Insights into the Biology of CLL
MC Lanasa |
Hematology | 2010 |
Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia
T Butler, JG Gribben |
Blood Reviews | 2010 |
NF-κB as a therapeutic target in chronic lymphocytic leukemia
M Lopez-Guerra, D Colomer |
Expert Opinion on Therapeutic Targets | 2010 |
Stereotypical Chronic Lymphocytic Leukemia B-Cell Receptors Recognize Survival Promoting Antigens on Stromal Cells
M Binder, B Léchenne, R Ummanni, C Scharf, S Balabanov, M Trusch, H Schlüter, I Braren, E Spillner, M Trepel, D Gullberg |
PloS one | 2010 |
MicroRNAs in Cancer Translational Research
WC Cho |
2010 | |
Molecular Pathology of Hematolymphoid Diseases
CH Dunphy |
2010 | |
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures
BR Minev |
2010 | |
Mechanisms of Oncogenesis
D Coppola |
2010 | |
A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence
N Darzentas, A Hadzidimitriou, F Murray, K Hatzi, P Josefsson, N Laoutaris, C Moreno, A Anagnostopoulos, J Jurlander, A Tsaftaris, N Chiorazzi, C Belessi, P Ghia, R Rosenquist, F Davi, K Stamatopoulos |
Leukemia | 2009 |
In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia
C Calissano, RN Damle, G Hayes, EJ Murphy, MK Hellerstein, C Moreno, C Sison, MS Kaufman, JE Kolitz, SL Allen, KR Rai, N Chiorazzi |
Blood | 2009 |
Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
E Kostareli, A Hadzidimitriou, N Stavroyianni, N Darzentas, A Athanasiadou, M Gounari, V Bikos, A Agathagelidis, T Touloumenidou, I Zorbas, A Kouvatsi, N Laoutaris, A Fassas, A Anagnostopoulos, C Belessi, K Stamatopoulos |
Leukemia | 2009 |
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study
R Bomben, MD Bo, D Capello, F Forconi, R Maffei, L Laurenti, D Rossi, MI Principe, A Zucchetto, F Bertoni, FM Rossi, P Bulian, I Cattarossi, F Ilariucci, E Sozzi, V Spina, E Zucca, M Degan, F Lauria, GD Poeta, DG Efremov, R Marasca, G Gaidano, V Gattei |
British Journal of Haematology | 2009 |
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance
M Dal-Bo, F Bertoni, F Forconi, A Zucchetto, R Bomben, R Marasca, S Deaglio, L Laurenti, DG Efremov, G Gaidano, GD Poeta, V Gattei |
Journal of Translational Medicine | 2009 |
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells
T Seiler, M Woelfle, S Yancopoulos, R Catera, W Li, K Hatzi, C Moreno, M Torres, S Paul, H Dohner, S Stilgenbauer, MS Kaufman, JE Kolitz, SL Allen, KR Rai, CC Chu, N Chiorazzi |
Blood | 2009 |
Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia
BT Messmer, BJ Raphael, SJ Aerni, GF Widhopf, LZ Rassenti, JG Gribben, NE Kay, TJ Kipps |
Leukemia Research | 2009 |
Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen
LA Sutton, E Kostareli, A Hadzidimitriou, N Darzentas, A Tsaftaris, A Anagnostopoulos, R Rosenquist, K Stamatopoulos |
Blood | 2009 |
Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors
S Tavolaro, S Chiaretti, M Messina, N Peragine, ID Giudice, M Marinelli, S Santangelo, FR Mauro, A Guarini, R Foà |
Leukemia Research | 2009 |
Chronic Lymphocytic Leukemia: New Concepts and Emerging Therapies
T Ahmadi, T Maniar, S Schuster, E Stadtmauer |
Current Treatment Options in Oncology | 2009 |
Prognostic markers in chronic lymphocytic leukemia: A comprehensive review
FV Bockstaele, B Verhasselt, J Philippé |
Blood Reviews | 2009 |
From pathogenesis to treatment of chronic lymphocytic leukaemia
T Zenz, D Mertens, R Küppers, H Döhner, S Stilgenbauer |
Nature Reviews Cancer | 2009 |
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis
MC Lanasa, SD Allgood, AD Volkheimer, JP Gockerman, JF Whitesides, BK Goodman, JO Moore, JB Weinberg, MC Levesque |
Leukemia | 2009 |
CLL: promiscuity leads to risks
K Stamatopoulos |
Blood | 2009 |
Gene Expression and Serum Cytokine Profiling of Low Stage CLL Identify WNT/PCP, Flt-3L/Flt-3 and CXCL9/CXCR3 as Regulators of Cell Proliferation, Survival and Migration
D Mahadevan, J Choi, L Cooke, B Simons, C Riley, T Klinkhammer, R Sud, S Maddipoti, S Hehn, H Garewal, C Spier |
Human genomics and proteomics : HGP | 2009 |
CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes
A Corcione, E Ferretti, M Bertolotto, F Fais, L Raffaghello, A Gregorio, C Tenca, L Ottonello, C Gambini, G Furtado, S Lira, V Pistoia |
PloS one | 2009 |
CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases
L Baseggio, A Traverse-Glehen, F Petinataud, E Callet-Bauchu, F Berger, M Ffrench, CM Couris, C Thieblemont, D Morel, B Coiffier, G Salles, P Felman |
Haematologica | 2009 |
How I treat CLL up front
JG Gribben |
Blood | 2009 |
Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia
R Sargent, D Jones, LV Abruzzo, H Yao, J Bonderover, M Cisneros, WG Wierda, MJ Keating, R Luthra |
The Journal of molecular diagnostics : JMD | 2009 |
Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia
RL Sargent, FE Craig, SH Swerdlow |
International journal of clinical and experimental pathology | 2009 |
Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia
M Hojjat-Farsangi, M Jeddi-Tehrani, SM Razavi, RA Sharifian, H Mellstedt, F Shokri, H Rabbani |
Cancer Science | 2009 |
Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders
H Nakahashi, N Tsukamoto, Y Hashimoto, H Koiso, A Yokohama, T Saitoh, H Uchiumi, H Handa, H Murakami, Y Nojima, M Karasawa |
Cancer Science | 2009 |
AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations
M Leuenberger, S Frigerio, PJ Wild, F Noetzli, D Korol, DR Zimmermann, C Gengler, NM Probst-Hensch, H Moch, M Tinguely |
Modern Pathology | 2009 |
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL
L Cro, F Morabito, N Zucal, S Fabris, M Lionetti, G Cutrona, F Rossi, M Gentile, A Ferrario, M Ferrarini, S Molica, A Neri, L Baldini |
Hematological Oncology | 2009 |
Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia
W Kern, F Dicker, S Schnittger, C Haferlach, T Haferlach |
Cytometry Part B: Clinical Cytometry | 2009 |
BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia
EJ Lewintre, CR Martín, CG Ballesteros, J Pendas, CB Campos, JR Ferrer, J García-Conde |
Leukemia & Lymphoma | 2009 |
CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia
W Xu, JY Li, YJ Wu, H Yu, QD Shen, T Tian, L Li, HX Qiu |
Leukemia Research | 2009 |
Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles
M Plander, S Seegers, P Ugocsai, S Diermeier-Daucher, J Iványi, G Schmitz, F Hofstädter, S Schwarz, E Orsó, R Knüchel, G Brockhoff |
Leukemia | 2009 |
The negative prognostic significance of positive direct antiglobulin test in Chinese patients with chronic lymphocytic leukemia
W Xu, JY Li, KR Miao, X Cao, Q Liu, L Fan, C Qiao, YJ Wu |
Leukemia & Lymphoma | 2009 |
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia
F Morabito, G Cutrona, M Gentile, S Matis, K Todoerti, M Colombo, C Sonaglio, S Fabris, D Reverberi, M Megna, M Spriano, E Lucia, E Rossi, V Callea, C Mazzone, G Festini, S Zupo, S Molica, A Neri, M Ferrarini |
British Journal of Haematology | 2009 |
Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: Molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns
RD Irons, A Le, L Bao, X Zhu, J Ryder, XQ Wang, M Ji, Y Chen, X Wu, G Lin |
Leukemia Research | 2009 |
CX3CR1 Is Expressed by Human B Lymphocytes and Meditates CX3CL1 Driven Chemotaxis of Tonsil Centrocytes
A Corcione, E Ferretti, M Bertolotto, F Fais, L Raffaghello, A Gregorio, C Tenca, L Ottonello, C Gambini, G Furtado, S Lira, V Pistoia, D Unutmaz |
PloS one | 2009 |
Neoplastic Hematopathology
D Jones |
2009 | |
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
AL Myhrinder, E Hellqvist, E Sidorova, A Soderberg, H Baxendale, C Dahle, K Willander, G Tobin, E Backman, O Soderberg, R Rosenquist, S Horkko, A Rosen |
Blood | 2008 |
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA
CC Chu, R Catera, K Hatzi, XJ Yan, L Zhang, XB Wang, HM Fales, SL Allen, JE Kolitz, KR Rai, N Chiorazzi |
Blood | 2008 |
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3
GF 2nd, CJ Goldberg, TL Toy, LZ Rassenti, WG Wierda, JC Byrd, MJ Keating, JG Gribben, KR Rai, TJ Kipps |
Blood | 2008 |
Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia
A Hadzidimitriou, N Darzentas, F Murray, T Smilevska, E Arvaniti, C Tresoldi, A Tsaftaris, N Laoutaris, A Anagnostopoulos, F Davi, P Ghia, R Rosenquist, K Stamatopoulos, C Belessi |
Blood | 2008 |
Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation
R Catera, GJ Silverman, K Hatzi, T Seiler, S Didier, L Zhang, M Hervé, E Meffre, DG Oscier, H Vlassara, RH Scofield, Y Chen, SL Allen, J Kolitz, KR Rai, CC Chu, N Chiorazzi |
Molecular Medicine | 2008 |
Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation
P Ghia, N Chiorazzi, K Stamatopoulos |
Journal of Internal Medicine | 2008 |
Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas
KA Field, S Charoenthongtrakul, JM Bishop, Y Refaeli |
Molecular Cancer | 2008 |
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia
FJ Li, S Ding, J Pan, MA Shakhmatov, E Kashentseva, J Wu, Y Li, S Soong, N Chiorazzi, RS Davis |
Blood | 2008 |
Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters
V Jurisic, N Colovic, N Kraguljac, HD Atkinson, M Colovic |
Medical Oncology | 2008 |
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
KI Lin, CS Tam, MJ Keating, WG Wierda, S O'Brien, S Lerner, KR Coombes, E Schlette, A Ferrajoli, LL Barron, TJ Kipps, L Rassenti, S Faderl, H Kantarjian, LV Abruzzo |
Blood | 2008 |
Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients
T Butler, JG Gribben |
Expert Opinion on Medical Diagnostics | 2008 |
Chronic lymphocytic leukaemia: An immunobiology approach
E Kostareli, T Smilevska, K Stamatopoulos, A Kouvatsi, A Anagnostopoulos |
Srpski arhiv za celokupno lekarstvo | 2008 |
Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident—With focus on immunoglobulin heavy chain gene analysis
I Abramenko, N Bilous, A Chumak, E Davidova, I Kryachok, Z Martina, S Nechaev, I Dyagil, D Bazyka, V Bebeshko |
Leukemia Research | 2008 |
MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
YO Huh, KI Lin, F Vega, E Schlette, CC Yin, MJ Keating, R Luthra, LJ Medeiros, LV Abruzzo |
British Journal of Haematology | 2008 |
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome
D Rossi, M Cerri, D Capello, C Deambrogi, FM Rossi, A Zucchetto, LD Paoli, S Cresta, S Rasi, V Spina, S Franceschetti, M Lunghi, C Vendramin, R Bomben, A Ramponi, G Monga, A Conconi, C Magnani, V Gattei, G Gaidano |
British Journal of Haematology | 2008 |
Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia
M Hojjat-Farsangi, M Jeddi-Tehrani, AA Amirzargar, SM Razavi, RA Sharifian, H Rabbani, F Shokri |
Human Immunology | 2008 |
Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia
L Chen, Y Zhang, W Zheng, Y Wu, C Qiao, L Fan, W Xu, J Li |
Leukemia Research | 2008 |
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabinein vitro
L Amrein, TA Hernandez, C Ferrario, J Johnston, SB Gibson, L Panasci, R Aloyz |
British Journal of Haematology | 2008 |
Molecular Profiling in CLL
JG Gribben |
Hematology | 2008 |
Molecular genetic characterization reveals new subsets of mantle cell lymphoma
EF Thelander, R Rosenquist |
Leukemia & Lymphoma | 2008 |
Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group
E Kimby, J Jurlander, C Geisler, H Hagberg, H Holte, T Lehtinen, B Östenstad, M Hansen, A Österborg, O Lindén, C Sundström, OB Gr |
Leukemia & Lymphoma | 2008 |
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia
L Galligan, MA Catherwood, C Matthews, TC Morris, HD Alexander |
Leukemia & Lymphoma | 2008 |
Chronic lymphocytic leukemia with mutated IgVH1-69 usage: A distinct CLL subgroup with more indolent behavior?
EM Hartmann, A Rosenwald |
Leukemia & Lymphoma | 2008 |
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia
S Fabris, L Mosca, K Todoerti, G Cutrona, M Lionetti, D Intini, S Matis, M Colombo, L Agnelli, M Gentile, M Spriano, V Callea, G Festini, S Molica, GL Deliliers, F Morabito, M Ferrarini, A Neri |
Genes, Chromosomes and Cancer | 2008 |
Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
AC Rawstron, FL Bennett, SJ O'Connor, M Kwok, JA Fenton, M Plummer, R Tute, RG Owen, SJ Richards, AS Jack, P Hillmen |
New England Journal of Medicine | 2008 |
Hematopathology
F Naeim |
Hematopathology | 2008 |
Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA)
V Grubor, A Krasnitz, JE Troge, JL Meth, B Lakshmi, JT Kendall, B Yamrom, G Alex, D Pai, N Navin, LA Hufnagel, YH Lee, K Cook, SL Allen, KR Rai, RN Damle, C Calissano, N Chiorazzi, M Wigler, D Esposito |
Blood | 2008 |
Chronic Lymphocytic Leukemia: The Role of MBL
P Ghia, A Rawstron |
Chronic Lymphocytic Leukemia: The Role of MBL | 2008 |
Use of V H, D and J H immunoglobulin gene segments in Brazilian patients with chronic lymphocytic leukaemia (CLL)
BJ Pimentel, CG Stefanoff, AS Moreira, HN Seuánez, IR Zalcberg |
Genetics and molecular biology | 2008 |
Molecular Genetic Pathology
L Cheng, DY Zhang |
2008 | |
Immunoglobulin Diversity Gene Usage Predicts Unfavorable Outcome in a Subset of Unmutated Chronic Lymphocytic Leukemia
Renee C. Tschumper, Susan M. Geyer, Megan E. Campbell, Neil E. Kay, Tait D. Shanafelt, Clive S. Zent, Grzegorz S. Nowakowski, Timothy G. Call, Gordon W. Dewald, and Diane F. Jelinek |
Journal of Clinical Investigation | 2007 |
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia
V Fulci, S Chiaretti, M Goldoni, G Azzalin, N Carucci, S Tavolaro, L Castellano, A Magrelli, F Citarella, M Messina, R Maggio, N Peragine, S Santangelo, FR Mauro, P Landgraf, T Tuschl, DB Weir, M Chien, JJ Russo, J Ju, R Sheridan, C Sander, M Zavolan, A Guarini, R Foà, G Macino |
Blood | 2007 |
Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells
LD Vallat, Y Park, C Li, JG Gribben |
Blood | 2007 |
Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia
T Motiwala, S Majumder, H Kutay, DS Smith, DS Neuberg, DM Lucas, JC Byrd, M Grever, ST Jacob |
Clinical cancer research | 2007 |
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
F Murray, N Darzentas, A Hadzidimitriou, G Tobin, M Boudjogra, C Scielzo, N Laoutaris, K Karlsson, F Baran-Marzsak, A Tsaftaris, C Moreno, A Anagnostopoulos, F Caligaris-Cappio, D Vaur, C Ouzounis, C Belessi, P Ghia, F Davi, R Rosenquist, K Stamatopoulos |
Blood | 2007 |
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells
RN Damle, S Temburni, C Calissano, S Yancopoulos, T Banapour, C Sison, SL Allen, KR Rai, N Chiorazzi |
Blood | 2007 |
Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia
G Roos, A Krober, P Grabowski, D Kienle, A Buhler, H Dohner, R Rosenquist, S Stilgenbauer |
Blood | 2007 |
Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology
LV Abruzzo, LL Barron, K Anderson, RJ Newman, WG Wierda, S O'brien, A Ferrajoli, M Luthra, S Talwalkar, R Luthra, D Jones, MJ Keating, KR Coombes |
The Journal of molecular diagnostics : JMD | 2007 |
Molecular genetic analysis of haematological malignancies II: mature lymphoid neoplasms
AJ Bench, WN Erber, GA Follows, MA Scott |
International Journal of Laboratory Hematology | 2007 |
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
D Gonzalez, M der Burg, R Garcia-Sanz, JA Fenton, AW Langerak, M Gonzalez, JJ van Dongen, JF san Miguel, GJ Morgan |
Blood | 2007 |
Krónikus limfoid leukémia: autoimmun betegség? Prognosztikai faktorok és a patogenezis mai értelmezése
L Pajor |
Orvosi Hetilap | 2007 |
The normal counterpart to the chronic lymphocytic leukemia B cell
F Caligaris-Cappio, P Ghia |
Best Practice & Research Clinical Haematology | 2007 |
Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells
N Chiorazzi |
Best Practice & Research Clinical Haematology | 2007 |
The immunoglobulin genes: Structure and specificity in chronic lymphocytic leukemia
GT PhD |
Leukemia & Lymphoma | 2007 |
Animal models for chronic lymphocytic leukemia
Y Pekarsky, N Zanesi, RI Aqeilan, CM Croce |
Journal of Cellular Biochemistry | 2007 |
Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MA Kharfan-Dabaja, R Fahed, M Hussein, ES Santos |
Expert Opinion on Investigational Drugs | 2007 |
Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?
MA Kharfan-Dabaja, A Kumar, M Behera, B Djulbegovic |
British Journal of Haematology | 2007 |
ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia
P Ghia, K Stamatopoulos, C Belessi, C Moreno, S Stilgenbauer, F Stevenson, F Davi, R Rosenquist |
Leukemia | 2007 |
Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia
L Muñoz, A Lasa, MT Carricondo, C Hernández, J Ubeda, JF Nomdedéu |
Cytometry Part B: Clinical Cytometry | 2007 |
Preclinical assessment of curcumin as a potential therapy for B-CLL
PC Everett, JA Meyers, A Makkinje, M Rabbi, A Lerner |
American Journal of Hematology | 2007 |
IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL)
Z Balogh, L Reiniger, L Deák, C Bödör, J Csomor, Á Szepesi, É Gagyi, L Kopper, A Matolcsy |
Hematological Oncology | 2007 |
Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome
L Terrin, L Trentin, M Degan, I Corradini, R Bertorelle, P Carli, N Maschio, MD Bo, F Noventa, V Gattei, G Semenzato, AD Rossi |
Leukemia | 2007 |
Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: An Evolving Concept
MA Kharfan-Dabaja, C Anasetti, ES Santos |
Biology of Blood and Marrow Transplantation | 2007 |
CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia
P Josefsson, CH Geisler, H Leffers, JH Petersen, MK Andersen, J Jurlander, AM Buhl |
Blood | 2007 |
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia
JB Weinberg, AD Volkheimer, Y Chen, BE Beasley, N Jiang, MC Lanasa, D Friedman, G Vaccaro, CW Rehder, CM DeCastro, DA Rizzieri, LF Diehl, JP Gockerman, JO Moore, BK Goodman, MC Levesque |
American Journal of Hematology | 2007 |
IgVH Mutational Status and Clonality Analysis of Richterʼs Transformation
Z Mao, L Quintanilla-Martinez, M Raffeld, M Richter, J Krugmann, C Burek, E Hartmann, T Rudiger, ES Jaffe, HK Müller-Hermelink, G Ott, F Fend, A Rosenwald |
The American Journal of Surgical Pathology | 2007 |
Gene therapy and active immune therapy of hematologic malignancies
WG Wierda, TJ Kipps |
Best Practice & Research Clinical Haematology | 2007 |
Prognostic markers in chronic lympocytic leukaemia
TJ Hamblin |
Best Practice & Research Clinical Haematology | 2007 |
The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia
TJ Kipps |
Best Practice & Research Clinical Haematology | 2007 |
Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia
MH Farsangi, M Jeddi-Tehrani, RA Sharifian, SM Razavi, J Khoshnoodi, H Rabbani, F Shokri |
Leukemia & Lymphoma | 2007 |
Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia
EA Nikitin, SG Malakho, BV Biderman, AV Baranova, YY Lorie, AY Shevelev, MM Peklo, TN Vlasik, EA Moskalev, BV Zingerman, IA Vorob'ev, AB Poltaraus, AB Sudarikov, AI Vorobjev |
Leukemia & Lymphoma | 2007 |
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia
GD Poeta, MI Principe, F Buccisano, L Maurillo, G Capelli, F Luciano, AP Perrotti, M Degan, A Venditti, P Fabritiis, V Gattei, S Amadori |
Cancer | 2007 |
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia
S Molica, G Cutrona, G Vitelli, R Mirabelli, M Molica, G Digiesi, D Ribatti, M Ferrarini, A Vacca |
Leukemia Research | 2007 |
Pathology of chronic lymphocytic leukemia: an update
KV Inamdar, CE Bueso-Ramos |
Annals of Diagnostic Pathology | 2007 |
Molecular Characterization of Complete and Incomplete Immunoglobulin Heavy Chain Gene Rearrangements in Hairy Cell Leukemia
P Martín-Jiménez, R García-Sanz, D González, A Balanzategui, JJ Pérez, MD Caballero, ME Sarasquete, J Galende, A Orfao, MC López-Berges, JF san Miguel, M González |
Clinical Lymphoma & Myeloma | 2007 |
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status
CI Mockridge, KN Potter, I Wheatley, LA Neville, G Packham, FK Stevenson |
Blood | 2007 |
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia
F Ghiotto, F Fais, E Albesiano, C Sison, A Valetto, G Gaidano, J Reinhardt, JE Kolitz, K Rai, SL Allen, M Ferrarini, N Chiorazzi |
Molecular Medicine | 2006 |
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia
X Yan, E Albesiano, N Zanesi, S Yancopoulos, A Sawyer, E Romano, A Petlickovski, DG Efremov, CM Croce, N Chiorazzi |
Proceedings of the National Academy of Sciences | 2006 |
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations
K Stamatopoulos, C Belessi, C Moreno, M Boudjograh, G Guida, T Smilevska, L Belhoul, S Stella, N Stavroyianni, M Crespo, A Hadzidimitriou, L Sutton, F Bosch, N Laoutaris, A Anagnostopoulos, E Montserrat, A Fassas, G Dighiero, F Caligaris-Cappio, H Merle-Béral, P Ghia, F Davi |
Blood | 2006 |
Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification
AD Volkheimer, JB Weinberg, BE Beasley, JF Whitesides, JP Gockerman, JO Moore, G Kelsoe, BK Goodman, MC Levesque |
Blood | 2006 |
B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens
E Sabattini, R Orduz, C Campidelli, PL Zinzani, V Callea, S Zupo, G Cutrona, F Morabito, M Ferrarini, S Pileri |
Journal of clinical pathology | 2006 |
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia
S Deaglio, T Vaisitti, S Aydin, E Ferrero, F Malavasi |
Blood | 2006 |
The biology and treatment of chronic lymphocytic leukemia
M Palma, P Kokhaei, J Lundin, A Choudhury, H Mellstedt, A Österborg |
Annals of Oncology | 2006 |
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells
D de Totero, R Meazza, S Zupo, G Cutrona, S Matis, M Colombo, E Balleari, I Pierri, M Fabbi, M Capaia, B Azzarone, M Gobbi, M Ferrarini, S Ferrini |
Blood | 2006 |
Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia
I Tinhofer, G Rubenzer, C Holler, E Hofstaetter, M Stoecher, A Egle, M Steurer, R Greil |
Blood | 2006 |
Novel Analysis of Clonal Diversification in Blood B Cell and Bone Marrow Plasma Cell Clones in Immunoglobulin Light Chain Amyloidosis
RS Abraham, MK Manske, NS Zuckerman, A Sohni, H Edelman, G Shahaf, MM Timm, A Dispenzieri, MA Gertz, R Mehr |
Journal of Clinical Immunology | 2006 |
Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia
S Ferri, FD Pero, G Bortoletto, FB Bianchi, M Lenzi, A Alberti, M Gerotto |
Journal of Viral Hepatitis | 2006 |
Pattern and Distribution of Immunoglobulin VH Gene Usage in a Cohort of B-CLL Patients From a Northeastern Region of Italy
PM Donisi, ND Lorenzo, M Riccardi, A Paparella, C Sarpellon, S Zupo, G Bertoldero, C Minotto, V Stracca-Pansa |
Diagnostic Molecular Pathology | 2006 |
Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia
H Koiso, A Yamane, T Mitsui, T Matsushima, N Tsukamoto, H Murakami, S Miyawaki, Y Nojima, M Karasawa |
Leukemia Research | 2006 |
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma
WJ Chng, RF Schop, T Price-Troska, I Ghobrial, N Kay, DF Jelinek, MA Gertz, A Dispenzieri, M Lacy, RA Kyle, PR Greipp, RC Tschumper, R Fonseca, PL Bergsagel |
Blood | 2006 |
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance
A Zucchetto, P Sonego, M Degan, R Bomben, MD Bo, P Bulian, D Benedetti, M Rupolo, GD Poeta, R Campanini, V Gattei |
Journal of Translational Medicine | 2006 |
Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein
A Mansour, VT Chang, S Srinivas, J Harrison, E Raveche |
Cancer Immunology, Immunotherapy | 2006 |
What is the current evidence for antigen involvement in the development of chronic lymphocytic leukemia?
G Tobin, A Rosén, R Rosenquist |
Hematological Oncology | 2006 |
Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells
EP Ryan, SJ Pollock, K Kaur, RE Felgar, SH Bernstein, N Chiorazzi, RP Phipps |
Clinical Immunology | 2006 |
Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells
C Bogner, M Sandherr, M Perker, K Weick, I Ringshausen, C Peschel, T Decker |
Annals of Hematology | 2006 |
B lymphocytes in humans express ZAP-70 when activatedin vivo
G Cutrona, M Colombo, S Matis, D Reverberi, M Dono, V Tarantino, N Chiorazzi, M Ferrarini |
European Journal of Immunology | 2006 |
Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome
S Kay, Y Herishanu, M Pick, O Rogowski, S Baron, E Naparstek, A Polliack, VR Deutsch |
Cytometry Part B: Clinical Cytometry | 2006 |
An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia
TV Shankey, M Forman, P Scibelli, J Cobb, CM Smith, R Mills, K Holdaway, E Bernal-Hoyos, MV der Heiden, J Popma, M Keeney |
Cytometry Part B: Clinical Cytometry | 2006 |
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor
R Zanotti, A Ambrosetti, M Lestani, P Ghia, C Pattaro, A Remo, F Zanetti, S Stella, O Perbellini, G Prato, G Guida, F Caligaris-Cappio, F Menestrina, G Pizzolo, M Chilosi |
Leukemia | 2006 |
Use of prognostic factors in risk stratification at diagnosis and time of treatment of patients with chronic lymphocytic leukemia
A Gowda, JC Byrd |
Current Opinion in Internal Medicine | 2006 |
CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia
A Hayat, D O'Brien, P O'Rourke, S McGuckin, T Fitzgerald, E Conneally, PV Browne, SR Mccann, MP Lawler, E Vandenberghe |
Leukemia & Lymphoma | 2006 |
Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd ζ-associated protein (ZAP-70)
U Schade, O Bock, S Vornhusen, A Jäger, G Büsche, U Lehmann, H Kreipe |
Human Pathology | 2006 |
ZAP-70 immunoreactivity is a prognostic marker of diseaseprogression in chronic lymphocytic leukemia
C Vener, U Gianelli, A Cortelezzi, NS Fracchiolla, F Somalvico, F Savi, MC Pasquini, S Bosari, GL Deliliers |
Leukemia & Lymphoma | 2006 |
Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: Evidence of simultaneous expansion of two independent clones
M Gottardi, V Gattei, M Degan, R Bomben, A Zucchetto, C Tecchio, L Laurino, L Zanatta, AP Tos, M Mordacchini, F Canal, F Gherlinzoni |
Leukemia & Lymphoma | 2006 |
Pattern and Distribution of Immunoglobulin VH Gene Usage in a Cohort of B-CLL Patients From a Northeastern Region of Italy:
PM Donisi, ND Lorenzo, M Riccardi, A Paparella, C Sarpellon, S Zupo, G Bertoldero, C Minotto, V Stracca-Pansa |
Diagnostic Molecular Pathology | 2006 |
Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis
A Athanasiadou, K Stamatopoulos, A Tsompanakou, M Gaitatzi, P Kalogiannidis, A Anagnostopoulos, A Fassas, A Tsezou |
Cancer Genetics and Cytogenetics | 2006 |
Evolving View of the In-Vivo Kinetics of Chronic Lymphocytic Leukemia B Cells
N Chiorazzi, M Ferrarini |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2006 |
Comprehensive characterization of IGHV3-21–expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study
R Bomben, MD Bo, D Capello, D Benedetti, D Marconi, A Zucchetto, F Forconi, R Maffei, EM Ghia, L Laurenti, P Bulian, MI Principe, G Palermo, M Thorsélius, M Degan, R Campanini, A Guarini, GD Poeta, R Rosenquist, DG Efremov, R Marasca, R Foà, G Gaidano, V Gattei |
Blood | 2006 |
Comprehensive characterization of IGHV3-21–expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study
R Bomben, MD Bo, D Capello, D Benedetti, D Marconi, A Zucchetto, F Forconi, R Maffei, EM Ghia, L Laurenti, P Bulian, MI Principe, G Palermo, M Thorsélius, M Degan, R Campanini, A Guarini, GD Poeta, R Rosenquist, DG Efremov, R Marasca, R Foà, G Gaidano, V Gattei |
Blood | 2006 |
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia
MI Principe, GD Poeta, F Buccisano, L Maurillo, A Venditti, A Zucchetto, R Marini, P Niscola, MA Consalvo, C Mazzone, L Ottaviani, P Panetta, A Bruno, R Bomben, G Suppo, M Degan, V Gattei, P de Fabritiis, M Cantonetti, FL Coco, DD Principe, S Amadori |
Blood | 2006 |
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia
C Mayr, MR Speicher, DM Kofler, R Buhmann, J Strehl, R Busch, M Hallek, CM Wendtner |
Blood | 2006 |
ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)
SJ Richardson, C Matthews, MA Catherwood, HD Alexander, BS Carey, J Farrugia, A Gardiner, S Mould, D Oscier, JA Copplestone, AG Prentice |
Blood | 2006 |
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.
Ghiotto F, Fais F, Albesiano E, Sison C, Valetto A, Gaidano G, Reinhardt J, Kolitz JE, Rai K, Allen SL, Ferrarini M, Chiorazzi N |
Molecular Medicine | 2006 |
In Vivo Measurements Document the Dynamic Cellular Kinetics of Chronic Lymphocytic Leukemia B Cells
Bradley T. Messmer, Davorka Messmer, Steven L. Allen, Jonathan E. Kolitz, Prasad Kudalkar, Denise Cesar, Elizabeth J. Murphy, Prasad Koduro, Manlio Ferrarini, Simona Zupo, Giovanna Cutrona, Rajendra N. Damle, Tarun Wasil, Kanti R. Rai, Marc K. Hellerstein, Nicholas Chiorazzi |
Journal of Clinical Investigation | 2005 |
Unmutated and mutated chronic lymphocytic leukemia derive from self-reactive B cell precursors despite expressing different antibody reactivity
Maxime Herve, Kai Xu, Yen-Shing Ng, Hedda Wardemann, Emilia Albesiano, Bradley T. Messmer, Nicholas Chiorazzi and Eric Meffre |
Journal of Clinical Investigation | 2005 |
HS1 protein, a target of B-cell-receptor signalling, is differentially expressed in Chronic Lymphocytic Leukemia subsets
Cristina Scielzo, Paolo Ghia, Antonio Conti, Angela Bachi, Giuseppe Guida, Massimo Geuna, Massimo Alessio and Federico Caligaris-Cappio |
Journal of Clinical Investigation | 2005 |
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
RJ Bende, WM Aarts, RG Riedl, D Jong, ST Pals, CJ van Noesel |
Journal of Experimental Medicine | 2005 |
Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia
K Mauerer, D Zahrieh, G Gorgun, A Li, J Zhou, S Ansén, LZ Rassenti, JG Gribben |
British Journal of Haematology | 2005 |
Immunoglobulin light chain repertoire in chronic lymphocytic leukemia
K Stamatopoulos, C Belessi, A Hadzidimitriou, T Smilevska, E Kalagiakou, K Hatzi, N Stavroyianni, A Athanasiadou, A Tsompanakou, T Papadaki, G Kokkini, G Paterakis, R Saloum, N Laoutaris, A Anagnostopoulos, A Fassas |
Blood | 2005 |
Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.
Tobin G, Rosenquist R |
Medical Oncology | 2005 |
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia
G Packham, FK Stevenson |
Immunology | 2005 |
Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia
R Marasca, R Maffei, M Morselli, P Zucchini, I Castelli, S Martinelli, M Fontana, S Ravanetti, M Curotti, G Leonardi, K Cagossi, G Partesotti, G Torelli |
The Journal of molecular diagnostics : JMD | 2005 |
Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling
A Zucchetto, P Sonego, M Degan, R Bomben, MD Bo, S Russo, V Attadia, M Rupolo, F Buccisano, MI Principe, GD Poeta, C Pucillo, A Colombatti, R Campanini, V Gattei |
Journal of Cellular Physiology | 2005 |
VH3 and VH6 Immunoglobulin M Repertoire Reconstitution after Hematopoietic Stem-Cell Transplantation in Children
DD Martino, MP Terranova, F Scuderi, PD Michele, S Iacovone, L Scarso, S Dallorso, G Dini, G Morreale, A Valetto |
Transplantation | 2005 |
Genetics and molecular biology of chronic lymphocytic leukemia
DA Carney, WG Wierda |
Current Treatment Options in Oncology | 2005 |
The Immunoglobulin genes and Chronic Lymphocytic Leukemia (CLL)
G Tobin |
Upsala Journal of Medical Sciences | 2005 |
Chronic Lymphocytic Leukemia
N Chiorazzi, KR Rai, M Ferrarini |
New England Journal of Medicine | 2005 |
Dissemination of a Sjögren's syndrome–associated extranodal marginal-zone B cell lymphoma: Circulating lymphoma cells and invariant mutation pattern of nodal Ig heavy- and light-chain variable-region gene rearrangements
A Hansen, K Reiter, A Pruss, C Loddenkemper, O Kaufmann, AM Jacobi, J Scholze, PE Lipsky, T Dörner |
Arthritis & Rheumatism | 2005 |
Mechanisms of B-cell lymphoma pathogenesis
R Küppers |
Nature Reviews Cancer | 2005 |
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia
GD Poeta, MI Principe, MA Consalvo, L Maurillo, F Buccisano, A Venditti, C Mazzone, A Bruno, L Gianní, G Capelli, FL Coco, M Cantonetti, V Gattei, S Amadori |
Cancer | 2005 |
Touch-Down Reverse Transcriptase-PCR Detection of IgVH Rearrangement and Sybr-Green-Based Real-Time RT-PCR Quantitation of Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia
S Pekov??, J Markov??, P Pajer, M Dvo????k, P Cetkovsk??, J Schwarz |
Molecular Diagnosis | 2005 |
Chronic lymphocytic leukemia: A review of some new aspects of the biology, factors influencing prognosis and therapeutic options
Y Herishanu, A Polliack |
Transfusion and Apheresis Science | 2005 |
Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia
ES Santos, M Masri, H Safah |
Expert Review of Anticancer Therapy | 2005 |
Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance
BS Lane, AA Mensah, K Lin, AR Pettitt, PD Sherrington |
Leukemia | 2005 |
Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation
SH Walsh, A Laurell, G Sundström, G Roos, C Sundström, R Rosenquist |
Leukemia Research | 2005 |
Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia
M Thorsélius, SH Walsh, U Thunberg, H Hagberg, C Sundström, R Rosenquist |
Leukemia Research | 2005 |
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance
A Zucchetto, P Sonego, M Degan, R Bomben, MD Bo, S Russo, V Attadia, M Rupolo, F Buccisano, A Steffan, GD Poeta, C Pucillo, A Colombatti, R Campanini, V Gattei |
Journal of Immunological Methods | 2005 |
CD38 as a prognostic marker in CLL
Z Matrai |
Hematology | 2005 |
Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation
WJ Mackus, AP Kater, A Grummels, LM Evers, B Hooijbrink, MH Kramer, JE Castro, TJ Kipps, RA van Lier, MH van Oers, E Eldering |
Leukemia | 2005 |
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status
P Grabowski, M Hultdin, K Karlsson, G Tobin, A Åleskog, U Thunberg, A Laurell, C Sundström, R Rosenquist, G Roos |
Blood | 2005 |
B Cell Response to Surface IgM Cross-Linking Identifies Different Prognostic Groups of B-Chronic Lymphocytic Leukemia Patients
S Nédellec, Y Renaudineau, A Bordron, C Berthou, N Porakishvili, PM Lydyard, JO Pers, P Youinou |
Journal of immunology (Baltimore, Md. : 1950) | 2005 |
ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia
L Chen, J Apgar, L Huynh, F Dicker, T Giago-McGahan, L Rassenti, A Weiss, TJ Kipps |
Blood | 2005 |
Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the μ and CD79a chains
F Vuillier, G Dumas, C Magnac, MC Prevost, AI Lalanne, P Oppezzo, E Melanitou, G Dighiero, B Payelle-Brogard |
Blood | 2005 |
Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia
S Fält, M Merup, G Tobin, U Thunberg, G Gahrton, R Rosenquist, A Wennborg |
Blood | 2005 |
Immunoglobulin Gene Analysis of Mature B-Cell Malignancies: Reconsideration of Cellular Origin and Potential Antigen Involvement in Pathogenesis
SH Walsh, R Rosenquist |
Medical Oncology | 2005 |
Touch-Down Reverse Transcriptase-PCR Detection of IgVH Rearrangement and Sybr-Green-Based Real-Time RT-PCR Quantitation of Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia:
S Pekov, J Markov, P Pajer, M Dvok, P Cetkovsk, J Schwarz |
Molecular Diagnosis | 2005 |
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival
S Deaglio, T Vaisitti, L Bergui, L Bonello, AL Horenstein, L Tamagnone, L Boumsell, F Malavasi |
Blood | 2004 |
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia
BT Messmer, E Albesiano, DG Efremov, F Ghiotto, SL Allen, J Kolitz, R Foa, RN Damle, F Fais, D Messmer, KR Rai, M Ferrarini, N Chiorazzi |
Journal of Experimental Medicine | 2004 |
Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia
D Capello, A Guarini, E Berra, FR Mauro, D Rossi, E Ghia, M Cerri, J Logan, R Foà, G Gaidano |
Leukemia | 2004 |
Ig V region restrictions in human chronic lymphocytic leukemia suggest some cases have a common origin
GR Kolar, JD Capra |
Journal of Clinical Investigation | 2004 |
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia
F Ghiotto, F Fais, A Valetto, E Albesiano, S Hashimoto, M Dono, H Ikematsu, SL Allen, J Kolitz, KR Rai, M Nardini, A Tramontano, M Ferrarini, N Chiorazzi |
Journal of Clinical Investigation | 2004 |
Mouse Models of Human Cancer
R Benezra, S Rafii, D Lyden |
Mouse Models of Human Cancer | 2004 |
Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status
D Messmer, G Telusma, T Wasil, BT Messmer, S Allen, KR Rai, N Chiorazzi |
Molecular Medicine | 2004 |
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia
D Lu, Y Zhao, R Tawatao, HB Cottam, M Sen, LM Leoni, TJ Kipps, M Corr, DA Carson |
Proceedings of the National Academy of Sciences | 2004 |
Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia
M Ferrarini, N Chiorazzi |
Seminars in Hematology | 2004 |
VH3-21 Gene Usage in Chronic Lymphocytic Leukemia – Characterization of a New Subgroup with Distinct Molecular Features and Poor Survival
G Tobin, O Söderberg, U Thunberg, R Rosenquist |
Leukemia & Lymphoma | 2004 |
Biallelic IgH rearrangements in patients with indolent lymphoproliferative disorders: Molecular and practical implications
J Cerny, A Slavickova, A Krepelova, M Trneny, J Karban, P Klener |
Journal of Cellular Physiology | 2004 |
Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research
F Bertoni, A Conconi, SB Cogliatti, SF Schmitz, M Ghielmini, T Cerny, M Fey, G Pichert, F Bertolini, M Ponzoni, L Baldini, C Jones, R Auer, E Zucca, F Cavalli, FE Cotter |
British Journal of Haematology | 2004 |
IgV gene intraclonal diversification and clonal evolution in B-cell chronic lymphocytic leukaemia
D Bagnara, V Callea, C Stelitano, F Morabito, S Fabris, A Neri, S Zanardi, F Ghiotto, E Ciccone, CE Grossi, F Fais |
British Journal of Haematology | 2004 |
CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma
V Franco, AM Florena, S Ascani, M Paulli, M Salvato, SA Pileri |
Histopathology | 2004 |
Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency
F Forconi, D Capello, E Berra, D Rossi, A Gloghini, M Cerri, G Muti, E Morra, M Paulli, U Magrini, M Lucioni, A Rambaldi, F Lauria, A Carbone, FK Stevenson, G Gaidano |
British Journal of Haematology | 2004 |
CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates ?-galactosylceramide presentation to natural killer T lymphocytes
F Fais, F Morabito, C Stelitano, V Callea, S Zanardi, M Scudeletti, P Varese, E Ciccone, CE Grossi |
International Journal of Cancer | 2004 |
Analysis of IgVH gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery
M Degan, R Bomben, MD Bo, A Zucchetto, P Nanni, M Rupolo, A Steffan, V Attadia, PF Ballerini, D Damiani, C Pucillo, GD Poeta, A Colombatti, V Gattei |
British Journal of Haematology | 2004 |
High expression of Bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia
AA Morales, A Olsson, F Celsing, A Österborg, M Jondal, LM Osorio |
International Journal of Cancer | 2004 |
The role of stem cell transplantation in chronic lymphocytic leukemia
V Rizouli, JG Gribben |
Seminars in Hematology | 2004 |
Novel therapies for chronic lymphocytic leukemia
BH Mavromatis, BD Cheson |
Blood Reviews | 2004 |
The Prognostic Value of CD38 Expression and its Quantification in B Cell Chronic Lymphocytic Leukemia (B-CLL)
T Mainou-Fowler, HM Dignum, SJ Proctor, GP Summerfield |
Leukemia & Lymphoma | 2004 |
Allelotyping in B-Cell Chronic Lymphocytic Leukemia (B-CLL)
U Novak, A Tobler, MF Fey |
Leukemia & Lymphoma | 2004 |
Clinical staging and prognostic markers in chronic lymphocytic leukemia
KR Rai, T Wasil, U Iqbal, N Driscoll, D Patel, D Janson, B Mehrotra |
Hematology/Oncology Clinics of North America | 2004 |
Perspectives in chronic lymphocytic leukemia biology and management
G Dighiero |
Hematology/Oncology Clinics of North America | 2004 |
Molecular genetics and its clinical relevance
S Stilgenbauer, H Döhner |
Hematology/Oncology Clinics of North America | 2004 |
The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model
F Caligaris-Cappio, P Ghia |
Hematology/Oncology Clinics of North America | 2004 |
Current Approach to Diagnosis and Management of Chronic Lymphocytic Leukemia
TD Shanafelt, TG Call |
Mayo Clinic Proceedings | 2004 |
Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins
GF 2nd, LZ Rassenti, TL Toy, JG Gribben, WG Wierda, TJ Kipps |
Blood | 2004 |
Microarray Gene Expression Profiling of B-Cell Chronic Lymphocytic Leukemia Subgroups Defined by Genomic Aberrations and VH Mutation Status
C Haslinger, N Schweifer, S Stilgenbauer, H Döhner, P Lichter, N Kraut, C Stratowa, R Abseher |
Journal of Clinical Oncology | 2004 |
Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia
E Sarsotti, I Marugan, I Benet, MJ Terol, D Sanchez-Izquierdo, M Tormo, F Rubio-Moscardo, JA Martinez-Climent, J García-Conde |
Leukemia | 2004 |
Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors
DM Kofler, H Büning, C Mayr, D Bund, J Baumert, M Hallek, CM Wendtner |
Gene Therapy | 2004 |
Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders
R Letestu, V Ugo, F Valensi, I Radford-Weiss, J Nataf, V Lévy, JG Gribben, X Troussard, F Ajchenbaum-Cymbalista |
Leukemia | 2004 |
Hematopathology in Oncology
WG Finn, LA Peterson |
2004 | |
Chronic lymphocytic leukemia: revelations from the B-cell receptor
FK Stevenson, F Caligaris-Cappio |
Blood | 2004 |
The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process
BT Messmer, E Albesiano, D Messmer, N Chiorazzi |
Blood | 2004 |
Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis
Yufen Qin, Pierre Duquette, Yiping Zhang, Michael Olek, Reng-Rong Da, John Richardson, Jack P Antel, Pierre Talbot, Neil R Cashman, Wallace W Tourtellotte, Hartmut Wekerle, Stanley Van Den Noort |
Laboratory Investigation | 2003 |
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations
RN Damle, FM Batliwalla, F Ghiotto, A Valetto, E Albesiano, C Sison, SL Allen, J Kolitz, VP Vinciguerra, P Kudalkar, T Wasil, KR Rai, M Ferrarini, PK Gregersen, N Chiorazzi |
Blood | 2003 |
Current Protocols in Cytometry
MC Monteiro, MJ Gon��alves, F Sansonetty, JE O'Connor |
Current Protocols in Cytometry | 2003 |
B CELLCHRONICLYMPHOCYTICLEUKEMIA: Lessons Learned from Studies of the B Cell Antigen Receptor
N Chiorazzi, M Ferrarini |
Annual Review of Immunology | 2003 |
Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications
M Hultdin, R Rosenquist, U Thunberg, G Tobin, KF Norrback, A Johnson, C Sundström, G Roos |
British Journal of Cancer | 2003 |
Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion
Y Miura, CC Chu, DM Dines, SE Asnis, RA Furie, N Chiorazzi |
Molecular Medicine | 2003 |
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations
A Tierens, J Delabie, A Malecka, J Wang, A Gruszka-Westwood, D Catovsky, E Matutes |
The American Journal of Pathology | 2003 |
Identification of oligoclonal CD4 T cells in diffuse large B cell lymphomas
H Li, X Ma, T Moskovits, G Inghirami, VK Tsiagbe |
Clinical Immunology | 2003 |
Prolegomenon for Chronic Lymphocytic Leukaemia
B Vitale, M Martinis, M Antica, B Kusic, S Rabatic, A Gagro, R Kusec, B Jaksic |
Scandinavian Journal of Immunology | 2003 |
ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia
M Crespo, F Bosch, N Villamor, B Bellosillo, D Colomer, M Rozman, S Marcé, A López-Guillermo, E Campo, E Montserrat |
New England Journal of Medicine | 2003 |
Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia
J Vilpo, G Tobin, J Hulkkonen, M Hurme, U Thunberg, C Sundström, L Vilpo, R Rosenquist |
European Journal of Haematology | 2003 |
B Cell Chronic Lymphocytic Leukemia
RN Damle, F Ghiotto, A Valetto, E Albesiano, SL Allen, P Schulman, VP Vinciguerra, KR Rai, M Ferrarini, N Chiorazzi |
Annals of the New York Academy of Sciences | 2003 |
Ex vivo drug and irradiation sensitivities in hypermutated and unmutated forms of chronic lymphocytic leukemia cells
I Kivekäs, G Tobin, U Thunberg, L Vilpo, C Sundström, R Rosenquist, J Vilpo |
Leukemia Research | 2003 |
Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope
G Tobin, U Thunberg, A Johnson, I Eriksson, O Söderberg, K Karlsson, M Merup, G Juliusson, J Vilpo, G Enblad, C Sundström, G Roos, R Rosenquist |
Blood | 2003 |
Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL
TD Shanafelt, SM Geyer, NE Kay |
Blood | 2003 |
Molecular Biology of B Cells
P Brandtzaeg, HC Morton, ME Lamm |
Molecular Biology of B Cells | 2003 |
Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL
C Magnac, R Porcher, F Davi, J Nataf, B Payelle-Brogard, RP Tang, P Oppezzo, V Lévy, G Dighiero, F Ajchenbaum-Cymbalista |
Leukemia | 2003 |
Anomalies génétiques des leucémies lymphoides chroniques
D Leroux, C Lefebvre, M Callanan |
Pathologie Biologie | 2003 |
Somatic Hypermutation Patterns in Germinal Center B Cell Malignancies
K Stamatopoulos, C Belessi, T Papadaki, N Stavroyianni, A Hadzidimitriou, C Kosmas, N Laoutaris, A Fassas, A Anagnostopoulos |
Hematology | 2003 |
Association between telomere length and VH gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications
M Hultdin, R Rosenquist, U Thunberg, G Tobin, KF Norrback, A Johnson, C Sundström, G Roos |
British Journal of Cancer | 2003 |
Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications
D González, A Balanzategui, R García-Sanz, N Gutiérrez, C Seabra, JJ van Dongen, M González, JF san Miguel |
Leukemia | 2003 |
Unsolved issues in CLL biology and management
G Dighiero |
Leukemia | 2003 |
Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome
B Timár, Z Fülöp, B Csernus, C Angster, Á Bognár, Á Szepesi, L Kopper, A Matolcsy |
Leukemia | 2003 |
Molekularmedizinische Grundlagen von hämatologischen Neoplasien
D Ganten, K Ruckpaul, B Schlegelberger, C Fonatsch |
2003 | |
Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features
A Guarini, G Gaidano, FR Mauro, D Capello, F Mancini, MS Propris, M Mancini, E Orsini, M Gentile, M Breccia, A Cuneo, G Castoldi, R Foa |
Blood | 2003 |
The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression
P Ghia, G Guida, S Stella, D Gottardi, M Geuna, G Strola, C Scielzo, F Caligaris-Cappio |
Blood | 2003 |
Biology and Treatment of Chronic Lymphocytic Leukemia
MJ Keating, N Chiorazzi, B Messmer, RN Damle, SL Allen, KR Rai, M Ferrarini, TJ Kipps |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2003 |
Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia
MR Rezvany, M Jeddi-Tehrani, H Wigzell, A Österborg, H Mellstedt |
Blood | 2003 |
Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia
M Ritgen, A Lange, S Stilgenbauer, H Döhner, C Bretscher, H Bosse, A Stuhr, M Kneba, P Dreger |
Blood | 2003 |
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome
D Kienle, A Kröber, T Katzenberger, G Ott, E Leupolt, TF Barth, P Möller, A Benner, A Habermann, HK Müller-Hermelink, M Bentz, P Lichter, H Döhner, S Stilgenbauer |
Blood | 2003 |
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone
E Albesiano, BT Messmer, RN Damle, SL Allen, KR Rai, N Chiorazzi |
Blood | 2003 |
New Directions in the Diagnosis and Treatment of Chronic Lymphocytic Leukaemia:
F Schriever, D Huhn |
Drugs | 2003 |
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia
DF Jelinek, RC Tschumper, SM Geyer, ND Bone, GW Dewald, CA Hanson, MJ Stenson, TE Witzig, A Tefferi, NE Kay |
British Journal of Haematology | 2002 |
The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes
KJ Till, K Lin, M Zuzel, JC Cawley |
Blood | 2002 |
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules
NE Kay, ND Bone, RC Tschumper, KH Howell, SM Geyer, GW Dewald, CA Hanson, DF Jelinek |
Leukemia | 2002 |
Decision making in the immune system: Lymphoid Malignancies: the dark side of B-cell differentiation
AL Shaffer, A Rosenwald, LM Staudt |
Nature Reviews Immunology | 2002 |
Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma
GD W. |
International Journal of Hematology | 2002 |
Mutation analysis of IgVH gene in B-cell chronic lymphocytic leukemia
W Feng, Z Huifen, Z Lijuan, Y Botao, S Guanxin |
Journal of Huazhong University of Science and Technology [Medical Sciences] | 2002 |
Malignant B Cells and Antigenic Receptor: Necessity or Habit?
B Ciric, LR Pease |
Leukemia & Lymphoma | 2002 |
Somatic hypermutation and VH gene usage in mantle cell lymphoma
M Thorselius, S Walsh, I Eriksson, U Thunberg, A Johnson, C Backlin, G Enblad, C Sundstrom, G Roos, R Rosenquist |
European Journal of Haematology | 2002 |
Molecular histogenesis of plasmablastic lymphoma of the oral cavity
G Gaidano, M Cerri, D Capello, E Berra, C Deambrogi, D Rossi, LM Larocca, E Campo, A Gloghini, U Tirelli, A Carbone |
British Journal of Haematology | 2002 |
Advances in classification and therapy of indolent B-cell malignancies
TJ Kipps |
Seminars in Oncology | 2002 |
Monitoring disease in lymphoma and CLL patients using molecular techniques
JG Gribben |
Best Practice & Research Clinical Haematology | 2002 |
GENEEXPRESSIONPROFILING OFLYMPHOIDMALIGNANCIES*
LM Staudt |
Annual Review of Medicine | 2002 |
Quantitative analysis of Cyclin D1 and CD23 expression in mantle cell lymphoma and B-chronic lymphocytic leukemia
H Koiso, N Tsukamoto, S Miyawaki, S Shinonome, Y Nojima, M Karasawa |
Leukemia Research | 2002 |
Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia
G Tobin, U Thunberg, A Johnson, I Thörn, O Söderberg, M Hultdin, J Botling, G Enblad, J Sällström, C Sundström, G Roos, R Rosenquist |
Blood | 2002 |
Chronic Lymphocytic Leukemia B Cells Can Undergo Somatic Hypermutation and Intraclonal Immunoglobulin V H DJ H Gene Diversification
C Gurrieri, P McGuire, H Zan, XJ Yan, A Cerutti, E Albesiano, SL Allen, V Vinciguerra, KR Rai, M Ferrarini, P Casali, N Chiorazzi |
Journal of Experimental Medicine | 2002 |
Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells
P Oppezzo, C Magnac, S Bianchi, F Vuillier, A Tiscornia, G Dumas, B Payelle-Brogard, F Ajchenbaum-Cymbalista, G Dighiero, O Pritsch |
Leukemia | 2002 |
Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
E Giné, F Bosch, N Villamor, M Rozman, D Colomer, A López-Guillermo, E Campo, E Montserrat |
Leukemia | 2002 |
The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia
MJ Dyer, DG Oscier |
Leukemia | 2002 |
Genetic susceptibility to chronic lymphocytic leukemia
RS Houlston, D Catovsky, Yuille |
Leukemia | 2002 |
Immunoglobulin diversification in B cell malignancies: internal splicing of heavy chain variable region as a by-product of somatic hypermutation
RJ Bende, WM Aarts, ST Pals, CJ van Noesel |
Leukemia | 2002 |
Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course
S Stilgenbauer, L Bullinger, P Lichter, H Döhner |
Leukemia | 2002 |
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia
L Chen, G Widhopf, L Huynh, L Rassenti, KR Rai, A Weiss, TJ Kipps |
Blood | 2002 |
Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course
P Algara, MS Mateo, M Sanchez-Beato, M Mollejo, IC Navas, L Romero, F Solé, M Salido, L Florensa, P Martı́nez, E Campo, MA Piris |
Blood | 2002 |
Do B-cell chronic lymphocytic leukemia patients with Ig VH3-21 genes constitute a new subset of chronic lymphocytic leukemia?
F Nollet, B Cauwelier, J Billiet, D Selleslag, AV Hoof, A Louwagie, A Criel |
Blood | 2002 |
Relationship between p53 dysfunction, CD38 expression, andIgVH mutation in chronic lymphocytic leukemia
K Lin, PD Sherrington, M Dennis, Z Matrai, JC Cawley, AR Pettitt |
Blood | 2002 |
Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia
CC Chang, J Lorek, DE Sabath, Y Li, CR Chitambar, B Logan, B Kampalath, RP Cleveland |
Blood | 2002 |
Ongoing In Vivo Immunoglobulin Class Switch DNA Recombination in Chronic Lymphocytic Leukemia B Cells
A Cerutti, H Zan, EC Kim, S Shah, EJ Schattner, A Schaffer, P Casali |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
A Kröber, T Seiler, A Benner, L Bullinger, E Brückle, P Lichter, H Döhner, S Stilgenbauer |
Blood | 2002 |
La Leucémie Lymphoïde Chronique : une maladie unique ou deux maladies distinctes ?
G Dighiero |
Bulletin de l'Académie nationale de médecine | 2002 |
Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development
Eric Meffre, Michèle Milili, Carla Blanco-Betancourt, Henedina Antunes, Michel C. Nussenzweig, Claudine Schiff |
Journal of Clinical Investigation | 2001 |
Survival of leukemic B cells promoted by engagement of the antigen receptor
A Bernal, RD Pastore, Z Asgary, SA Keller, E Cesarman, HC Liou, EJ Schattner |
Blood | 2001 |
Circulating human B cells that express surrogate light chains display a unique antibody repertoire
E Meffre, M Chiorazzi, MC Nussenzweig |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor
N Chiorazzi, M Ferrarini |
Annual Review of Immunology | 2001 |
Immunoglobulin Heavy Chain Variable Region (VH) Genes of B Cell Chronic Lymphocytic Leukemia Cells from Lymph Nodes Show Somatic Mutations and Intraclonal Diversity Irrespective of Follicular Dendritic Cell Network
K Isobe, JI Tamaru, T Uno, S Yasuda, T Aruga, S Itoyama, K Harigaya, A Mikata, H Ito |
Leukemia & Lymphoma | 2001 |
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma
R Marasca, P Vaccari, M Luppi, P Zucchini, I Castelli, P Barozzi, A Cuoghi, G Torelli |
The American Journal of Pathology | 2001 |
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells
U Klein, Y Tu, GA Stolovitzky, M Mattioli, G Cattoretti, H Husson, A Freedman, G Inghirami, L Cro, L Baldini, A Neri, A Califano, R Dalla-Favera |
Journal of Experimental Medicine | 2001 |
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, OK Pickeral, LZ Rassenti, J Powell, D Botstein, JC Byrd, MR Grever, BD Cheson, N Chiorazzi, WH Wilson, TJ Kipps, PO Brown, LM Staudt |
Journal of Experimental Medicine | 2001 |
Somatic hypermutation shapes the antibody repertoire of memory B cells in humans
E Meffre, N Catalan, F Seltz, A Fischer, MC Nussenzweig, A Durandy |
Journal of Experimental Medicine | 2001 |
New aspects on the pathogenesis, diagnostic procedures, and therapeutic management of chronic lymphocytic leukemia
CM Wendtner, B Schmitt, M Bergmann, T Röhnisch, R Buhmann, M Hallek |
International Journal of Hematology | 2001 |
Gene expression profiling of lymphomas
U Hegde, WH Wilson |
Current Oncology Reports | 2001 |
Analysis of Clonal Relationship Using Single-Cell Polymerase Chain Reaction in a Patient with Concomitant Mantle Cell Lymphoma and Multiple Myeloma
M Yamaguchi, T Ohno, E Miyata, H Toyoda, K Nishii, M Masuya, K Kita, H Shiku |
International Journal of Hematology | 2001 |
Somatic Hypermutation Shapes the Antibody Repertoire of Memory B Cells in Humans
E Meffre, N Catalan, F Seltz, A Fischer, MC Nussenzweig, A Durandy |
Journal of Experimental Medicine | 2001 |
Secondary ocular involvement in systemic “memory” B-cell lymphocytic leukemia
SE Coupland, HD Foss, NE Bechrakis, M Hummel, H Stein |
Ophthalmology | 2001 |
Immunotherapy of chronic lymphocytic leukemia
WG Wierda, S O’Brien |
Expert Review of Anticancer Therapy | 2001 |
Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia
F Morabito, M Mangiola, B Oliva, C Stelitano, V Callea, S Deaglio, P Iacopino, M Brugiatelli, F Malavasi |
Leukemia Research | 2001 |
Human CD38: a (r)evolutionary story of enzymes and receptors
S Deaglio, K Mehta, F Malavasi |
Leukemia Research | 2001 |
Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia
T Mainou-Fowler, SJ Proctor, S Miller, AM Dickinson |
Leukemia & Lymphoma | 2001 |
Clinical significance of CD38 expression in chronic lymphocytic leukemia
GD Poeta, L Maurillo, A Venditti, F Buccisano, AM Epiceno, G Capelli, A Tamburini, G Suppo, A Battaglia, MI Principe, BD Moro, M Masi, S Amadori |
Blood | 2001 |
Lack of allelic exclusion and isotype switching in B cell chronic lymphocytic leukemia
Y Katayama, A Sakai, S Katsutani, Y Takimoto, A Kimura |
American Journal of Hematology | 2001 |
Significance of phosphotyrosine proteins, Bcl-2 and p53 for apoptosis in resting b-chronic lymphocytic leukemia (CLL) cells
N Laytragoon-Lewin, ED Rossmann, J Castro, H Mellstedt |
International Journal of Cancer | 2001 |
Common Germinal-Center B-Cell Origin of the Malignant Cells in Two Composite Lymphomas, Involving Classical Hodgkin’s Disease and Either Follicular Lymphoma or B-CLL
R Küppers, AB Sousa, AS Baur, JG Strickler, K Rajewsky, ML Hansmann |
Molecular Medicine | 2001 |
Gene Expression Profiling by Microarrays: Clinical Implications
WK Hofmann |
2001 | |
Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol
A Noy, R Verma, M Glenn, P Maslak, ZU Rahman, JR Keenan, M Weiss, D Filippa, AD Zelenetz |
Blood | 2001 |
Normal B Cells Express 51p1 -Encoded Ig Heavy Chains That Are Distinct From Those Expressed by Chronic Lymphocytic Leukemia B Cells
GF Widhopf, TJ Kipps |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
V H 1-69 gene is preferentially used by hepatitis C virus–associated B cell lymphomas and by normal B cells responding to the E2 viral antigen
CH Chan, KG Hadlock, SK Foung, S Levy |
Blood | 2001 |
CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia
Z Matrai, K Lin, M Dennis, P Sherrington, M Zuzel, AR Pettitt, JC Cawley |
Blood | 2001 |
Chronic Lymphocytic Leukemia: Case-Based Session
KR Rai, H Döhner, MJ Keating, E Montserrat |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2001 |
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia
S Ibrahim, M Keating, KA Do, S O'Brien, YO Huh, I Jilani, S Lerner, HM Kantarjian, M Albitar |
Blood | 2001 |
Normal B Cells Express 51p1 -Encoded Ig Heavy Chains That Are Distinct From Those Expressed by Chronic Lymphocytic Leukemia B Cells
GF Widhopf, TJ Kipps |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
CD5-positive B cells in healthy elderly humans are a polyclonal B cell population
KD Geiger, U Klein, A Bräuninger, S Berger, K Leder, K Rajewsky, ML Hansmann, R Küppers |
European Journal of Immunology | 2000 |
Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes
K Itoh, E Meffre, E Albesiano, A Farber, D Dines, P Stein, SE Asnis, RA Furie, RI Jain, N Chiorazzi |
Journal of Experimental Medicine | 2000 |
Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types
DW Bahler, NS Aguilera, CC Chen, SL Abbondanzo, SH Swerdlow |
The American Journal of Pathology | 2000 |
Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells
MS Gordon, RM Kato, F Lansigan, AA Thompson, R Wall, DJ Rawlings |
Proceedings of the National Academy of Sciences | 2000 |
Biology of Chronic Lymphocytic Leukemia
F Caligaris-Cappio |
Reviews in Clinical and Experimental Hematology | 2000 |
Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia
MR Rezvany, M Jeddi-Tehrani, H Rabbani, U Ruden, L Hammarstrom, A Osterborg, H Wigzell, H Mellstedt |
British Journal of Haematology | 2000 |
Immunoglobulin Heavy Chain Variable Region Gene Replacement as a Mechanism for Receptor Revision in Rheumatoid Arthritis Synovial Tissue B Lymphocytes
K Itoh, E Meffre, E Albesiano, A Farber, D Dines, P Stein, SE Asnis, RA Furie, RI Jain, N Chiorazzi |
Journal of Experimental Medicine | 2000 |
New Concepts in the Pathogenesis, Diagnosis, Prognostic Factors and Clinical Presentation of Chronic Lymphocytic Leukemia
M Hallek |
Reviews in Clinical and Experimental Hematology | 2000 |
Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia
MR Rezvany, M Jeddi-Tehrani, H Rabbani, N Lewin, J Avila-Carino, Osterborg, H Wigzell, H Mellstedt |
British Journal of Haematology | 2000 |
Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County
RP Gale, W Cozen, MT Goodman, FF Wang, L Bernstein |
Leukemia Research | 2000 |
Cancer and Autoimmunity
O Pritsch, G Dighiero |
Cancer and Autoimmunity | 2000 |
Aberrant B cell receptor signaling from B29 (Igbeta , CD79b) gene mutations of chronic lymphocytic leukemia B cells
MS Gordon, RM Kato, F Lansigan, AA Thompson, R Wall, DJ Rawlings |
Proceedings of the National Academy of Sciences | 2000 |
Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients
M Colombo, M Dono, P Gazzola, S Roncella, A Valetto, N Chiorazzi, GL Mancardi, M Ferrarini |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
CD5 Is A Potential Selecting Ligand for B-Cell Surface Immunoglobulin: A Possible Role in Maintenance and Selective Expansion of Normal and Malignant B Cells
R Pospisil, GJ Silverman, GE Marti, A Aruffo, MA Bowen, RG Mage |
Leukemia & Lymphoma | 2000 |
Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution?
A Husebekk, V Fellowes, EJ Read, J Williams, MJ Petrus, RE Gress, DH Fowler |
Cytotherapy | 2000 |
Diagnostic Pathology
S Sheikh, D Garvin |
Diagnostic Pathology | 2000 |
PCR Analysis of Immunoglobulin Heavy Chain (IgH) and TcR-γ Chain Gene Rearrangements in the Diagnosis of Lymphoproliferative Disorders: Results of a Study of 525 Cases
C Thériault, S Galoin, S Valmary, J Selves, L Lamant, D Roda, F Rigal-Huguet, P Brousset, G Delsol, TA Saati |
Modern Pathology | 2000 |
Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes
D Capello, F Fais, D Vivenza, G Migliaretti, N Chiorazzi, G Gaidano, M Ferrarini |
Leukemia | 2000 |
B1 Lymphocytes in B Cell Neoplasia
M Potter, F Melchers |
2000 | |
High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH
J Shaughnessy, E Tian, J Sawyer, K Bumm, R Landes, A Badros, C Morris, G Tricot, J Epstein, B Barlogie |
Blood | 2000 |
Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin VH genes show frequent use of V1-69 with distinctive CDR3 features
JA Miklos, SH Swerdlow, DW Bahler |
Blood | 2000 |
Heterogeneity of Tonsillar Subepithelial B Lymphocytes, the Splenic Marginal Zone Equivalents
M Dono, S Zupo, N Leanza, G Melioli, M Fogli, A Melagrana, N Chiorazzi, M Ferrarini |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Hodgkin and Reed-Sternberg–like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell–derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease
H Kanzler, R Küppers, S Helmes, HH Wacker, A Chott, ML Hansmann, K Rajewsky |
Blood | 2000 |
Somatic mutation of bcl-6 genes can occur in the absence of VH mutations in chronic lymphocytic leukemia
SS Sahota, Z Davis, TJ Hamblin, FK Stevenson |
Blood | 2000 |
Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD
S Zupo, R Massara, M Dono, E Rossi, F Malavasi, ME Cosulich, M Ferrarini |
Blood | 2000 |
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
WG Wierda, MJ Cantwell, SJ Woods, LZ Rassenti, CE Prussak, TJ Kipps |
Blood | 2000 |
Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis
K Itoh, V Patki, RA Furie, EK Chartash, RI Jain, L Lane, SE Asnis, N Chiorazzi |
Arthritis research | 1999 |
Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment
M Montesinos-Rongen, R Küppers, D Schlüter, T Spieker, DV Roost, C Schaller, G Reifenberger, OD Wiestler, M Deckert-Schlüter |
The American Journal of Pathology | 1999 |
Restricted immunoglobulin variable region (Ig V) gene expression accompanies secondary rearrangements of light chain Ig V genes in mouse plasmacytomas
L Diaw, D Siwarski, A Coleman, J Kim, GM Jones, G Dighiero, K Huppi |
Journal of Experimental Medicine | 1999 |
Chronic lymphocytic leukemia
WG Wierda, TJ Kipps |
Current Opinion in Hematology | 1999 |
VH gene usage by family members affected with chronic lymphocytic leukaemia
O Pritsch, X Troussard, C Magnac, FR Mauro, F Davi, B Payelle-Brogard, G Dumas, M Pulik, F Clerget, F Mandelli, N Chiorazzi, HW Schroeder, M Leporrier, G Dighiero |
British Journal of Haematology | 1999 |
Sjögren's syndrome comes of age
JM Anaya, N Talal |
Seminars in Arthritis and Rheumatism | 1999 |
Cellular Origin of Human B-Cell Lymphomas
FH Epstein, R Küppers, U Klein, ML Hansmann, K Rajewsky |
New England Journal of Medicine | 1999 |
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
RN Damle, T Wasil, F Fais, F Ghiotto, A Valetto, SL Allen, A Buchbinder, D Budman, K Dittmar, J Kolitz, SM Lichtman, P Schulman, VP Vinciguerra, KR Rai, M Ferrarini, N Chiorazzi |
Blood | 1999 |
Mechanisms of B Cell Neoplasia 1998
F Melchers, M Potter |
1999 | |
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
RN Damle, T Wasil, F Fais, F Ghiotto, A Valetto, SL Allen, A Buchbinder, D Budman, K Dittmar, J Kolitz, SM Lichtman, P Schulman, VP Vinciguerra, KR Rai, M Ferrarini, N Chiorazzi |
Blood | 1999 |
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
TJ Hamblin, Z Davis, A Gardiner, DG Oscier, FK Stevenson |
Blood | 1999 |
Analysis of the B-Cell Receptor B29 (CD79b) Gene in Familial Chronic Lymphocytic Leukemia
B Payelle-Brogard, C Magnac, FR Mauro, F Mandelli, G Dighiero |
Blood | 1999 |
Genetic Engineering
P Little |
Genetic Engineering | 1981 |